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Abstract
In Swaziland, cases of cervical cancer among Human Immunodeficiency Virus (HIV)positive adolescent girls and young women (AGYW) are increasing, but there is low uptake
of cervical cancer screening. This study was conducted using the systems thinking theory to
explore the relationships between the uptake of cervical cancer screening among HIVpositive AGYW in Swaziland and the availability of trained health providers, cervical
screening services, and the provision of referrals for cervical screening. The study also
investigated any differences in uptake of cervical screening based on age group. For this
quantitative cross-sectional study, secondary HIV program data that were collected routinely
between January 2016 and March 2018 were accessed. Data were described with univariate
analysis while relationships were tested using bivariate analysis and logistic regression.
Most facilities (97%) had staff who had been trained; facilities with greater numbers of
trained staff were more likely to have a higher uptake (OR: 30.3, p = 0.000). Facilities with
cervical screening services were also more likely to have a higher uptake (x2 = 16.94, p =
0.000), and facilities with all the core components for screening had the highest uptake (p =
0.002). AGYW who had a positive screen were referred equally but the referral rate was low
(20.45%). There was no difference in uptake by age group. The results of the study can
increase knowledge of the institutional factors that contribute to the low uptake of cervical
cancer screening among HIV-positive AGYW and has implications for social change by
informing interventions for improving cervical cancer screening uptake in HIV-positive
AGYW in similar settings, ultimately reducing the high costs, morbidity, and mortality
related to cervical cancer in this population.
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1
Section 1: Foundation of the Study and Literature Review
Introduction
HIV-infected women are affected with cervical cancer because HIV accelerates
the progression of cervical dysplasia and cancer if they are infected with human
papilloma virus (HPV; Mbulaiteye, Bhatia, Adebamowo, & Sasco, 2011). In Swaziland,
cervical cancer is the leading cause of cancer related deaths and fourth leading cause of
all deaths among women regardless of HIV status (Bruni et al., 2016). The high mortality
rate for women with cervical cancer in Swaziland is associated with advanced disease at
diagnosis (Bruni et al., 2016), which is partly due to low rates of early detection
(Gyenwali, Pariyar, & Onta, 2013). Cervical cancer is classified as an AIDS defining
illness and therefore cervical cancer screening is recommended within basic HIV care for
women and screening uptake is a proxy indicator for HIV program performance among
women (Franceschi & Jaffe, 2007; Ports, Haffejee, Mosavel, & Rameshbabu, 2015). The
most recent World Health Organization (WHO) guidelines on cervical cancer screening
recommend screening from the age of 21 and every 3 years after that except in special
populations like women infected with HIV (WHO, 2013b). The guidelines recommend
screening at first HIV diagnosis in those with non-perinatally acquired HIV and every
year after that regardless of age (WHO, 2013b).
Despite the importance of cervical cancer screening to prevent the morbidity and
mortality related to cervical cancer, the uptake of cervical cancer screening among HIVinfected AGYW remains very low in Swaziland (Jolly et al., 2017). Studies that have
been conducted in other sub-Saharan countries provide multiple reasons for the low
uptake of cervical cancer screening among women but not among AGYW specifically
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(Bayu, Berhe, Mulat, & Alemu, 2016; Rosser, Njoroge, & Huchko, 2016). For this
review, the reasons have been grouped according to the individual, the social support
systems, the health systems (institutional), and policy environment (Hoque, Ghuman,
Coopoosmay, & Van Hal, 2014; Ncube, Bey, Knight, Bessler, & Jolly, 2015; Roncancio,
Ward, & Fernandez, 2013). Women often do not access screening because they are not
aware of cervical cancer, are not aware of the availability of the screening services, or are
afraid of the results of the screening (Kasting et al., 2016; Lyimo & Beran, 2012a).
Women who access the screening services report that peer support or a community
referral or a health provider referral influenced their decision to screen (Akinyemiju,
2012; Bayu et al., 2016; Jia et al., 2013). Health care providers report that they can
provide screening services if the environment is enabling with policy, guidelines, and
infrastructure (Brouwers et al., 2011; Ndejjo et al., 2016; Ntekim, 2012). Political support
for the scale-up of screening services also supports the uptake of the cervical screening
(Ntekim, 2012).
Among AGYW, health care access is suboptimal (Dellar, Dlamini, & Karim,
2015), especially among HIV-infected populations where stigma and discrimination
related to HIV is predominant (Ralph & Brindis, 2010; Tsai, Lin, Chou, & Lin, 2014;
Villalobos et al., 2017). In Tanzania, an estimated 50% of adolescents become sexually
active and about 25% of adolescents give birth, but reproductive health services are
nonexistent and health care access for pregnant young women is limited (Hokororo et al.,
2015). In Nigeria, adolescents and youth account for 46% of the population but their
health service use is low. The reasons for the low health care service use include services
that are not appropriate for adolescents and young people, misinformation or bias toward
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adolescents who seek reproductive health services, long distances to facilities that
provide youth friendly services, and the cost of the services (Azfredrick, 2016). In
Swaziland, there is limited evidence available describing use of health care services by
AGYW in general with even less evidence of the determinants of cervical screening
among this population, yet they are the most affected by HIV and cervical cancer is on
the rise in this group (Finocchario-Kessler et al., 2016a; Kim, Campos, O’Shea, Diaz, &
Mutyaba, 2013). Thus, I investigated the health institutional determinants of cervical
cancer screening among HIV infected AGYW in Swaziland to provide evidence that
public health practitioners may use to inform and improve cervical cancer prevention
programming to increase cervical cancer awareness, prevention, and early detection
among HIV-infected AGYW thereby reducing morbidity and mortality caused by
cervical cancer.
Problem Statement
Despite the rise in cervical cancer rates among AGYW, that is expected to double
over the next 10 years in the HIV-infected populations in sub-Saharan Africa, there is a
lack of evidence regarding the determinants of uptake of cervical cancer screening in this
population that could inform interventions (Boardman & Robison, 2013; Bynum et al.,
2016; Finocchario-Kessler et al., 2016). HIV-infected AGYW are a growing population
in sub-Saharan Africa whose health care needs are not being addressed (Kirby, 2016;
Ramjee & Daniels, 2013; Sommer, 2011). Due to their positions in society, they are more
likely to have poor HIV treatment outcomes and present with an AIDS defining illness
such as cervical cancer (Dellar et al., 2015). The late presentation with cervical cancer
leads to high morbidity and mortality rates as well as increased health care costs. In 2016,

4
the Swaziland cancer registry showed that out of 2,000 women who received cervical
cancer screening, 65% were HIV-infected AGYW. Among the HIV-infected AGYW
who were screened, 45% had cervical abnormalities and 20% had late stage cervical
cancer, proportions much higher than the AGYW who did not have HIV (Swaziland
Ministry of Health, 2016). However, cervical cancer is curable when detected early,
suggesting a lack in the preventative health systems that delay the early diagnosis of
cervical lesions in the HIV-infected AGYW population in Swaziland. There is a need for
interventions that promote AGYW’s well-being and longevity informed by evidence
generated from research (Department of Maternal Newborn Child and Adolescent Health,
2012; Sommer & Mmari, 2015) such as this study.
Purpose of the Study
Cervical cancer is a major contributor of morbidity and mortality among Swazi
women and especially HIV-infected AGYW (Information Centre on HPV and Associated
Cancers, 2016; Swaziland Ministry of Health, 2016). These women are at increased risk
of cervical cancer partly because of their low participation rates in preventative cancer
screening programs and their HIV infection (Swaziland Ministry of Health, 2015b).
Therefore, the purpose of this study was to investigate the relationships between health
care institutional factors and young HIV-infected Swazi women’s participation in
cervical cancer screening using secondary quantitative data.
Although there are studies on barriers to the uptake of cervical cancer screening in
HIV-infected women, no age disaggregation is usually provided though it has been
established that AGYW are a vulnerable population with their own specific barriers that
need to be addressed (Bailey, 2012). Understanding the health system barriers for this
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vulnerable population is critical to reducing the morbidity and mortality rates from
cervical cancer in this population (WHO, 2013). This quantitative study had four main
independent variables: the availability of screening services in health facilities, the
presence of staff who are trained to do cervical cancer screening, the provision of
referrals to eligible women to attend cervical cancer screening, and age bracket of the
woman undergoing cervical cancer screening. The dependent variable was the uptake of
cervical cancer screening. Most of the studies on cervical cancer screening uptake are
qualitative and do not quantify the extent of the problem or describe significant
relationships between institutional factors and cervical cancer screening uptake
(Akinyemiju et al, 2015; Dulla, Daka, & Wakgari, 2017; Kasting et al., 2016;
Visanuyothin, Chompikul, & Mongkolchati, 2015; Wood et al., 2016).
Research Questions
The research questions allowed for the description of the relationship between the
selected health care institutional factors and the uptake of cervical cancer screening
among the target population.
Research Question 1: What is the relationship between the availability of trained
health providers and the uptake of cervical cancer screening among HIV-positive
adolescent girls and young women in Swaziland?
H01: There is no relationship between the availability of trained health care
providers and the rate of uptake of cervical cancer screening among HIV-positive
adolescent girls and young women.
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Ha1: There is a relationship between the availability of trained health care
providers and the uptake of cervical cancer screening among HIV-positive adolescent
girls and young women.
Research Question 2: What is the relationship between the availability of cervical
cancer screening services in a facility and the uptake of cervical cancer screening among
HIV-positive adolescent girls and young women in Swaziland?
H02: There is no relationship between the availability of cancer screening services
within a facility and the uptake of cervical cancer screening.
Ha2: There is a relationship between the availability of cervical cancer screening
services within a facility and the uptake of cervical cancer screening.
Research Question 3: What is the relationship between the provision of a referral
for cervical cancer screening among eligible HIV positive adolescent girls and young
women and the uptake of cervical cancer screening among HIV-positive adolescent girls
and young women in Swaziland?
H03: There is no relationship between the provision of a referral for cervical
cancer screening in eligible women and the uptake of cervical cancer screening.
Ha3: There is a relationship between the provision of a referral for cervical cancer
screening in eligible women and the uptake of cervical cancer screening.
Research Question 4: Is there a difference in uptake of cervical cancer screening
between HIV-positive adolescent girls and HIV-positive young women?
H04: There is no difference in uptake of cervical cancer screening between HIVpositive adolescent girls and HIV-positive young women.
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Ha4: There is a difference in uptake of cervical cancer screening between HIVpositive adolescent girls and HIV-positive young women.
Theoretical Framework
I used the systems thinking theory to guide the research. The systems thinking
theory was first proposed by Ludwig von Bertalanffy in the 1940s and further refined by
Ross Ashby in 1956 (Peters, 2014). Von Bertanalanffy proposed this theory to highlight
the unity of science (Cordon, 2013). He posited that systems are open to and interact with
their environments and that their natures can change through gaining new properties
resulting in continual evolution with improvements (Peters, 2014). Proponents of the
systems theory posit that for a system to work, all parts are interlinked and support each
part (Diez Roux, 2011; Luke & Stamatakis, 2012).
The health system needs to improve to address safety, quality, and cost and
become more patient centered and focused on patient health outcomes. One method that
has been used in other industries to address similar gaps is a systems thinking approach to
improvement (Peters, 2014). The systems approach has not been used traditionally in the
health industry; however, industries that have used a systems approach have reported
improvements in quality and value. A systems approach incorporates all elements that
influence health and their interactions (Jeffcott, 2014; Leischow & Milstein, 2006).
However, there is a challenge in addressing the cultural, structural and technological
barriers and is further compounded by ensuring that the health improvements are centered
on the patients and engage the patients (Cordon, 2013).
Shortfalls occur in health care despite health care providers spending time and
effort caring for the patients, illustrating that the problem may be with the design and
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implementation of the multiple systems in health care. The more complex the health care
required by the patients, the more likely they are to experience multiple incidences of
harm including the loss of dignity and respect (Arnold & Wade, 2015; Roberts, Fisher,
Trowbridge, & Bent, 2016). One instance of harm is the failure to provide patient with
relevant care like AGYW who should receive cervical cancer screening but do not
(Peters, 2014). Many of the public health programs add unnecessary burden to clinical
work and remove the focus from the patient (Parham et al., 2015). The lack of standard
procedures and measurements leads to issues in providing care (Black, 2013; Reeve et al.,
2013). The introduction of technology into health systems has also affected efficiency
and limited interoperability between data repositories, making health systems even more
unwieldy (Gaynor, Yu, Andrus, Bradner, & Rawn, 2014; Iroju, Soriyan, Gambo, &
Olaleke, 2013). However, if e-technology for health were incorporated adequately,
productivity would increase and health care costs related to data would reduce (Cardoso,
Marins, Portela, Abelha, & Machado, 2014; Iroju et al., 2013). The solution to the
challenges in the health care system is to understand and attempt to address the
nonfunctioning processes and to use a systems approach in doing so (Braithwaite, 2018;
Carayon et al., 2014) and create a sustainable health system that promotes and supports
the practice of the health care provider.
A systems approach can improve health care by considering the multiple elements
involved in providing care for patients and the multiple determinants of health.
Understanding the functioning and interactions of these elements can help plan, design,
and integrate processes, policies, organizations, and people to provide cost efficient
health care (Elkins & Gorman, 2013). The systems theory approach can be applied to all
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levels of the health system such as the health facility, regional health management teams,
public health programs, and the ministry of health officials. Specific tools that include
problem identification tools, resource use, and human factor engineering to identify
safety, quality, and reliability challenges are used in the application of the systems theory
(Cordon, 2013). Additionally, using a systems approach requires data management
systems, supportive leadership, engagement of patients, families and health care
providers, and a potential to remodel the existing health care pathways (Htway & Casteel,
2015).
Systems thinking concepts in health care can apply to any health care system from
prevention of disease to end of life care. Public health systems are multilayered and
multifaceted and for each layer to function optimally, there should be close interactions
between relevant layers or facets (Peters, 2014). This consists of policy makers both in
the local environment like the local government and the external environment like the
WHO as well as structures and groups of individuals in institutions and agencies that
influence and implement the way health care is delivered. The components of systems
thinking include the environment in that the system exists; the inputs like technology,
workforce, infrastructure, quality management; expected outputs like people receiving
care they need; the processes involved like screening, diagnosis, treatment; the hierarchy
that governs the system from policy makers to care providers; whether the system is goal
-driven; and information available regarding the system.
Failures of cervical cancer screening programs have been attributed to failures in
system quality management rather than failure of technology (Nygård, 2011). The goal of
the systems quality management is to confirm that women in targeted demographic
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groups are screened and receive appropriate follow-up (McGraw & Ferrante, 2014). The
parts of the system are related to the four-level model of health systems (individual,
interpersonal, institution, and community), that can be used to outline the factors that
affect the uptake of cervical cancer screening in targeted groups of women (Huchko,
Bukusi, & Cohen, 2011). For this research, I focused on the institutional or supply-side
factors and the health care providers, cervical cancer screening infrastructure, and patient
management systems in the current health care system in Swaziland.
Nature of the Study
The nature of this study was quantitative. The methodology of a study is
determined by the issue the researcher is examining, the research questions, and the type
of data to be analyzed (Kothari, Kumar, & Uusitalo, 2014). Because secondary data were
used in this study, it was a cross-sectional analytical retrospective survey (Rabinovich,
2011). Data were sourced from the Ministry of Health’s Health Management Information
Systems (HMIS). All AGYW registered in HIV care were eligible for inclusion in the
data review. Data were triangulated from the national service availability and readiness
assessment (SARA) 2017, the HIV client management system, and the national training
information system. The common denominator to these datasets was the unique facility
identity number.
The independent variables included:
•

the availability of screening services in health facilities, that involved cervical
cancer screening equipment, the ability to perform on-site treatment or link
patients to appropriate treatment services, advertisement of screening services
in the clinic service listing.
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•

the presence of staff who are trained to do cervical cancer screening as
recognized by the sexual reproductive health program as being able to
perform the screening.

•

the provision of referrals to eligible women to attend cervical cancer
screening. Health care providers are required to complete and provide the
national referral form for screening services and the referral should be
documented in the facility registration logbook. Hence, this variable was
extracted to calculate the proportion of eligible women provided with a
referral and whether there is a significant relationship between providing a
referral and uptake of the screening.

•

the age bracket of the woman undergoing cervical cancer screening. The
young HIV-infected women were disaggregated into adolescents 15-18 and
young women 19-24. Due to transition in maturity, lifestyle, and legal rights
that happen between these ages, the uptake of cervical cancer screening
services was expected to be different between the two age groups.

The dependent variable was the uptake of cervical cancer screening, that was
defined as the acceptance and receipt of cervical cancer screening in an eligible woman
or women. Additional factors that were assessed include locality of the clinic (rural or
urban) and ownership of the facility, as these may impact on the availability of the cancer
screening services. The key study variables were extracted into one database and
analyzed. The data were described using univariate analysis and bi- and multi-variate
analyses including binomial logistic regression were conducted to test relationships using
SPSS software.
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Literature Review Search Criteria
In this section, I review the public health literature related to cervical cancer
screening among HIV-infected AGYW. Where the literature was limited or unavailable,
reference was made to HIV-infected women in general. I identified the need for
continued research to examine the systemic factors that determine uptake of cervical
cancer screening among HIV-infected AGYW in Swaziland. Several studies have
identified the importance of youth friendly services that incorporate cervical cancer
screening and reproductive health (Hokororo et al., 2015; Jolly et al., 2017; Miller,
Hanson, Johnson, Royalty, & Richardson, 2014; Mwaniki et al., 2014), but there is still a
lack of literature providing evidence on the barriers to cervical cancer screening among
HIV-infected AGYW despite cervical cancer being on the rise in this population.
I conducted the literature search from peer-reviewed journals, WHO, and cervical
cancer organizations as well as country level reports on health care access to services for
AGYW. The databases included MEDLINE with full text, Science Direct, Science
Citation Index Expanded and CINAHL Plus with full text. The search terms key phrases
and words included HIV infected adolescents, HIV infected young women, Cervical
cancer Screening, Cervical cancer screening programs, Cervical Cancer Prevention. I
considered articles that were published from 2013 to now. Seminal works in adolescent
reproductive health that were older than 5 years were also reviewed if they had additional
information on the variables being explored. The articles that contributed to the literature
presented were entered into a matrix that outlined the article title, purpose of the article,
year of publication, and contributing information.
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Literature Review
HIV-infected Adolescent Girls and Young Women
Young women are defined as girls and women between the ages of 15 and 24.
However, because of the significant transition in maturity, lifestyle, and legal rights that
happen between these ages, they are further subdivided as adolescent girls 15-18 and
young women 18-24 (Dellar et al., 2015). This distinction is important to design
interventions that address the vulnerabilities of each age group (Abdool Karim, Baxter, &
Birx, 2017). For instance, sexually active adolescent girls are increasingly being
recognized as a population distinct from adult women (Boardman & Robison, 2013;
Bynum et al., 2016). They are at a high risk of acquiring the HPV, but most infections
and cervical intraepithelial lesions caused by HPV are cleared by the immune system, so
most recent guidelines for cervical cancer screening do not recommend routine screening
in women less than 21 years of age (WHO, 2013b). However, a retrospective review of
the data in an academic medical clinic in the United States showed that there may be an
increased risk of developing invasive cancer between the recommended screening
intervals (Nitschmann, May, Mirkovic, & Feldman, 2016).
HIV-infected AGYW who are sexually active form a special population requiring
cervical cancer screening because the incidence of preinvasive cervical cancer (cervical
intraepithelial neoplasia), as confirmed by colposcopy, is 4 to 5 times higher in HIVinfected women and adolescents compared to HIV-negative women and adolescents with
high-risk sexual behaviors (Memiah et al., 2012). Cervical intraepithelial neoplasia is
common in HIV-infected women because:
•

Both HIV and HPV are sexually transmitted
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•

HIV-infected women are more likely to have persistent HPV infection

•

Persistent infection with one or more oncogenic HPV subtypes is a major
factor in the pathogenesis of premalignant and malignant cervical disease

HIV-infected women who develop cervical intraepithelial neoplasia tend to have more
aggressive disease and therefore guidelines for the prevention and treatment of
opportunistic infections in adults and adolescents including HPV-related disease
recommend screening should be initiated within 1 year of onset of sexual activity but no
later than 21 years old, and the screening should continue throughout the woman’s
lifetime unlike the general population that ends at 65 years old (Grellier & Quéro, 2014).
These guidelines also recommend that cervical screening be done at the time of the initial
diagnosis of HIV and repeated every 12 months thereafter.
In sub-Saharan Africa where the HIV epidemic is concentrated, there is a lack of
information on cervical cancer screening implementation in women 15 to 24 years old
(Coleman et al., 2016; Parham et al., 2015). However, studies conducted on women
generally reveal low rates of uptake of cervical cancer screening from 3% to 33%
(Boardman & Robison, 2013; Bruni et al., 2016), with resulting high incident rates of
cervical cancer—age standardized rates between 29.3 and 42.7 (Obi & Ozumba, 2014)—
and high mortality rates from the disease (Bruni et al., 2016; Coleman et al., 2016;
Maseko, Chirwa, & Muula, 2015c; Obi & Ozumba, 2014) .
Cervical Cancer Screening
Burden of Cervical Cancer
Cancer of the cervix, a preventable and treatable cancer, is a public health issue
worldwide. It is the fourth most common cancer among women and seventh most
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common cancer among people globally (Bruni et al., 2016). The age standardized
cervical cancer incidence and mortality rates in low resource countries are almost twice
than in higher resource countries where cervical cancer screening is routine (Dunne &
Park, 2013; Mboumba Bouassa et al., 2017). On an annual basis, about 500,000 new
cases are reported of which 85% are in developing countries (Bruni et al., 2016).
Annually 266,000 women die from cervical cancer, and almost 90% of them are in
developing countries (Finocchario-Kessler et al., 2016). The presence of systematic
population-based screening in developed countries is to a large extent the reason for the
large differences in cervical cancer related morbidity and mortality (WHO, 2013). These
screening programs have reduced incidence and mortality by up to 60% and 75%
respectively over the last three decades (Vacarella et al., 2016). For example, in England,
a population-based case-control study that used data recorded between 1998 and 2013
indicated that screening prevents 70% (95% CI: 66–73%) of cervical cancer deaths (all
ages), and this was improved among women who were screened regularly to 83% (95%
CI: 82–84%; Landy, Pesola, Castañón, & Sasieni, 2016).
Sub-Saharan Africa has the world’s highest age-standardized incidence rates of
cervical cancer with the highest incidence reported in Malawi (75.9 per 100,000;
Mboumba Bouassa et al., 2017). Swaziland has the seventh highest age-standardized
incidence rate at 53.1 per 100,000 women with an estimated 233 women being diagnosed
annually and 188 dying from the disease annually (Bruni et al., 2016). Despite being one
of the preventable cancers, cervical cancer is the leading cause of cancer deaths among
women in Swaziland. Typically, cervical cancer affects women older than 40 years of age
and progresses very slowly; however, in Swaziland, the epidemiology of cervical cancer
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has changed due to the high HIV prevalence (32% among people 18-49) and is frequent
in younger age groups (20-35; Swaziland Ministry of Health, 2016). The cancer is
aggressive and associated with poor outcomes. Studies and reports developed in
Swaziland showed that younger women are diagnosed with more aggressive forms of the
cervical cancer more commonly in the HIV-infected population (Information Centre on
HPV and Associated Cancers, 2016; Jolly et al., 2017; Malambo & Erikson, 2017;
Swaziland Ministry of Health, 2016).
Importance of Addressing Cervical Cancer Burden
The need to address cervical cancer in developing countries is related to the
impact on the health of women and by extension their families in society and the impact
on the health system (WHO, 2013). The social impact of the loss of women in their
reproductive and economically productive phase in their lives impacts not only their
families but the society in which they live. Women are responsible for the well-being of
the family and by extension the community. The impact on the health system is related to
the prohibitive costs related to treating women with late stage disease that requires
specialized health care and expensive medications as compared to preventing or detecting
and treating early stage disease using low cost, low resource cervical screening (WHO,
2014b). A cost analysis conducted in South Africa found that screening and early
treatment of cervical cancer precursors cost 80% less than treating invasive cervical
cancer (Knegt, 2014).
What is Cancer of the Cervix?
Cancer is described as an atypical growth of cells (Information Centre on HPV
and Associated Cancers, 2016). Cancer of the cervix is an abnormal growth of the
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squamous cells of the cervix (also referred to as the entrance of the uterus). The atypical
cells mature rapidly, function different to typical cervical cells, and their appearance is
also different. In advanced disease, the cancer is characterized with invasion of other
tissues both near and distant from the cervix such as the bladder, bones, and the lungs
(Aziz & Aziz, 2016). This disease spread is usually via the hematogenous route.
What Causes Cancer of the Cervix?
The primary cause of cancer of the cervix is chronic infection with HPV (ElKhatib, Tota, & Kaufmann, 2012). Known as the silent infection, HPV is one of the most
common sexually-transmitted infections (Dunne & Park, 2013). HPV infection is cleared
by about 75% of women who get the infection, and in the remaining 25% who get the
chronic infection between 60%-70% will go on to develop cancer of the cervix (Ibeanu,
2011). Cancer of the cervix grows slowly and with little symptomatology until later in the
disease. Cervical cells that are chronically infected with HPV transform into atypical
cells that form the precancerous stage, and high grade and anaplastic cells are precursors
to invasive cervical cancer (Castellsague et al., 2012). Women who may have been
infected in the teens, 20s, or early 30s may not manifest cervical cancer until 15 to 20
years later.
What are the Main Risk Factors?
There are multiple risk factors associated with the development of cervical cancer,
but the most important ones include age, immune suppression, HPV infection, sexual
behavior, smoking, hormonal factors, and genetics (Bruni et al., 2016; Georgia Cancer
Centre, 2016):
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Age. Any woman who has been sexually active is at risk of developing cervical
cancer, and the risk increases as a woman gets older. The most consistent predictor of
risk for cervical cancer is age. However, AGYW are more predisposed for precancerous
lesions due to their physiology as well as riskier sexual behavior but are more likely to
clear HPV infections (Van Kerrebroeck & Makar, 2016).
Immune suppression. Immune suppression, especially related to HIV infection,
accelerates the development of cervical cancer (Thorsteinsson et al., 2016). Cervical
cancer is an AIDS defining illness because HIV accelerates the disease progression
(Kelly et al., 2018; Tirelli, Bernardi, & Vaccher, 2001). Women with HIV and HPV
infection are 3 times more likely to develop cervical cancer than women who do not have
HIV (Mukanyangezi et al., 2018; Thorsteinsson et al., 2016). Additionally, the cervical
cancer in these women is aggressive.
HPV infection. Between 60% to 70% of the women with chronic HPV infection
who account for about 5%-15% of women ever infected with HPV will go on to develop
cancer of the cervix later in life (Petry, 2014). However, research has shown that
persistent infection with high risk strain types of HPV combined with other factors, such
as smoking and immunosuppression, cause the majority of cervical cancer cases (Murillo,
Herrero, Sierra, & Forman, 2016; Richard et al., 2015).
Sexual behavior. Early sexual debut, multiple sexual partners, and unsafe sex
increase a woman’s exposure to HPV infection (Martín-Hernán, Sánchez-Hernández,
Cano, Campo, & del Romero, 2013). Sexual behavior is not an independent risk factor
for the development of cervical cancer and therefore other risk factors must be present as
well (Bruni et al., 2016).
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Smoking, hormonal factors, and genetics. In women with cervical dysplasia,
tobacco use may play an influencing role in the development of cervical cancer
(Castellsague et al., 2012; Matsumoto et al., 2010).Early age at first birth, extended use of
contraceptives, and multiple births influence the development of cervical cancer (Roura
et al., 2016). Research is providing more information regarding the risk of certain genetic
profiles in women that predispose them to cervical cancer. However, this is not used
routinely in the clinical or public health setting (Hu et al., 2015).
Cervical Cancer Prevention
Primary prevention and secondary prevention are two interventions that can be
used for cervical cancer prevention (WHO, 2014b).
Primary prevention. Primary prevention includes preventing infection with HPV
or reducing the exposure to HPV infection (McGraw & Ferrante, 2014). Preventing HPV
infection is achieved through vaccination against HPV in girls and boys who are not yet
sexually active (El-Khatib et al., 2012). In many developed countries, HPV vaccination
has been offered routinely since early 2000, while in developing countries, HPV
vaccination is only starting to be available to vaccination programs. Vaccination against
HPV has reduced HPV infections by more than 80% in countries where the uptake of the
vaccination remains at above 75% (McGraw & Ferrante, 2014). Reducing exposure to
HPV is usually achieved by means of safer sex practices such as delayed sexual debut,
use of barrier methods during sexual intercourse, and monogamy. Because HPV infection
does not present with any symptoms in infected individuals and sexuality is a challenge
to change with varied success, reducing transmission of HPV in the absence of
vaccination is a major public health challenge. The sexual transmission of HPV infection
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is driven by many factors other than the individual’s character such as poverty, gender
norms that promote female subjugation, religious and cultural norms that frown on
condom use, and situations that expose individuals to sexual violence (Kasting et al.,
2016).
Secondary prevention (cervical cancer screening). Secondary prevention is
currently the mainstay for prevention of cancer of the cervix in many developing
countries while HPV vaccination is being scaled up. Secondary prevention of cancer of
the cervix involves the early discovery and treatment of high grade precancerous lesions
of the cervix and more recently testing for the presence of HPV in the cells of the cervix
even before there are precancerous lesions (Parkhurst & Vulimiri, 2013). Early detection
of precursors of cervical cancer is achieved through visually examining the cervix using
different methods. Cervical cancer screening is applied to two groups of women (Randall
& Ghebre, 2016b):
•

Women who have high grade precancerous lesions in the cervix. The
development of cancer of the cervix can be curtailed if these lesions are
diagnosed early and treated promptly.

•

Women who do not have any lesions. Routine HPV testing enables the
identification of women who are higher risk of developing precancerous
lesions and allows them to receive cervical screening in a timely manner as
well as reduce unnecessary cervical screening and cytology. This is an
important tool in situations where cytology is a challenge like in Swaziland.

Over the last three decades, cervical cancer screening has evolved from using
cytology-based tests to DNA testing for HPV and more recently to the availability of self-
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testing, thus improving access to screening for cervical cancer (Boone, Erickson, & Huh,
2012; Castle & Cremer, 2013; Sarai Racey, Withrow, & Gesink, 2013). However, in low
resource settings like Swaziland, cytological testing is still the standard practice but has
evolved from the traditional PAP smear to a “see-and-treat” method with visual
inspection with acetic acid methodology (Akinyemiju et al., 2015; Lince-Deroche et al.,
2015; Parham et al., 2015). See-and-treat methods reduce the number of visits a client
needs to make to receive results and treatment thus improving the retention in care as
well as the access to services and the uptake of the services by the women (Bruni et al.,
2016). Cervical cytology detects early stages of cervical cancer when it can be cured
preventing the morbidity and mortality associated with cervical cancer.
Cervical Cancer Screening Programs
Programmatic evaluations and research have demonstrated that systematic
cervical cancer screening programs that are carefully planned out, can successfully
reduce the number of new cases and deaths due to cervical cancer (McGraw & Ferrante,
2014). In several European countries where population based cervical cancer screening
programs are institutionalized, the incidence of cervical cancer has decreased by more
than 60% (Vaccarella et al., 2014). The high mortality due to cervical cancer in
developing countries has been attributed to ineffective cervical cancer screening
programs (Randall & Ghebre, 2016b). Evidence suggests that while sixty percent of
women in high resource countries have undergone cervical cancer screening, only about
20% of women in low resource countries have undergone a cervical cancer screening
(Mukakalisa, Bindler, Allen, & Dotson, 2014).
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The challenges involved in preventing cervical cancer in developing countries are
numerous however, one major barrier is the inability to have integrated, comprehensive
and systematic cervical cancer screening programs (Catarino, Petignat, Dongui, &
Vassilakos, 2015b; Mukakalisa et al., 2014). These programs must have a set of essential
components (WHO, 2014b) that include:
•

Availability of culturally appropriate informational, educational and
communication strategies that are informed by audience segmentation to
create demand for the cervical cancer services within the community.

•

Building capacity of the service providers to increase awareness about
cervical cancer prevention, how to diagnose and treat early as well as improve
their skills at conducting the screening. This can be achieved through training
that addresses both improvements in technical skills and patient education and
counseling skills.

•

Health facilities are able to provide cervical cancer screening services with
functional systems to ensure the obtaining and subsequent processing of
cervical samples are adhered to in a timely and quality assured manner.

•

Health facilities have systems in place to ensure delivery of the results to the
clients including an active tracking mechanism for women at high risk who do
not honor their scheduled appointments.

•

The availability of referral and linkage systems for women with abnormal
results to ensure that these women receive appropriate care interventions in a
timely manner.
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•

Health facilities that provide cervical cancer treatment are available and
accessible for women in need of treatment.

•

Monitoring and evaluation systems to ensure availability of statistics and
information to inform programming.

Within developing countries in Sub-Saharan Africa, there has been limited impact
of cervical cancer screening programs mainly because the programs are opportunistic and
not systematic (Randall & Ghebre, 2016b). The program only reaches women who come
to health facilities for other health issues or when they are symptomatic for cervical
cancer. Although the infrastructure to provide the screening services may be available,
the quality of services provided is weak due to inadequate numbers of trained and skilled
health providers and there is poor utilization of services by the women due to inadequate
demand creation programs to raise awareness, traditional beliefs that prevent the women
from seeking sexual reproductive health services (gynecological examination is a cause
of embarrassment or a taboo) or inaccessible health services (Catarino, Petignat, Dongui,
& Vassilakos, 2015a; Finocchario-Kessler et al., 2016; Kasting et al., 2016).
Additionally, Health ministries do not invest resources required to maintain a population
based organized screening service.
Cervical Cancer Screening in Swaziland
Over the last three decades in line with the HIV clinical management guidelines
in Swaziland, there have been multiple attempts to introduce a systematic cervical
screening program (Jolly et al., 2017). The initial programs were unsuccessful because
cervical cancer prevention was not a government priority in the face of a raging HIV
epidemic. The national Health policy does not specifically refer to cervical cancer
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prevention but makes a general statement that cancer prevention efforts should be
available within the health care settings (Swaziland Ministry of Health, 2015a). The HIV
clinical management guidelines provide recommendations for cervical cancer screening
among the HIV infected girls and women, but cervical cancer screening is not routinely
or systematically provided to this population. Cervical cancer screening occurs in pockets
around the country, often in facilities situated in urban areas where access to cytology
services is easy and almost invariably linked to family planning services (Swaziland
Central Statistics Office & World Bank, 2014). Thus, women with accessible health care
and who are often at lower risk for cervical cancer, have more opportunity to receive
cervical cancer screening and do receive it, while those without access who are often not
clients of the family planning services are left out. This neglected population includes
HIV infected AGYW in the rural areas (Fletcher et al., 2014).
In 2016, the Swaziland Cancer Registry reported that of 2000 women who had
received a cervical cancer screening, 45% were found to have cervical abnormalities that
included atypical cells, precancerous cells and early stages of neoplasia of which the
precancerous cells and early stages of neoplasia are precursors to cervical cancer
(Swaziland Ministry of Health, 2016). Of those with cervical abnormalities, 62% were
HIV infected and all were between the ages of 17 and 35 years. The data from the HIV
information system indicated that there were approximately 300,000 people infected with
HIV of which 180,000 were women. Adolescent girls and Young women aged 25 years
and less, made up 38% of this population (Swaziland National AIDS Program, 2016). In
2015, 3,000 HIV infected women had ever received a cervical cancer screen which was
less than 2% of the HIV infected female population (Swaziland Ministry of Health,
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2015b). These findings illustrate the low coverage of cervical cancer screening services
in Swaziland that ultimately has a negative bearing on reducing the number of new cases
of cervical cancer and the number of cervical cancer related deaths. Furthermore, the
differences in cervical cancer morbidity and mortality between urban and rural women is
in part caused by the differences in access to the screening services (Swaziland Central
Statistics Office & World Bank, 2014).
In 2015, the Ministry of Health prioritized cervical cancer prevention thus
demonstrating political will to tackle this issue. However, since the declaration, there has
been very little effort by the government to develop a policy or invest resources to
advance the program, relying on donor funding and implementing partners to implement
cervical cancer screening within the health facilities. Additionally, the economic
recession facing the country has hindered the implementation of many vital health
programs including the cervical cancer screening program. With no guiding policy,
cervical cancer screening efforts remain at the discretion of the sexual reproductive health
program, the HIV/AIDS program and individual health facilities and these efforts are not
coordinated (Jolly et al., 2017; Swaziland Ministry of Health, 2015b; Swaziland National
AIDS Program, 2016).
Barriers to Cervical Cancer Screening
Design and implementation of Public health interventions depend on the
documentation of the distribution (morbidity, mortality, life expectancy, etc.) and the
determinants of health including equity, access to and quality of health services. Within
health services, public health deals with preventive services such as screening or
vaccination, as well as with health promotion and health care management. Addressing
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service provision for cervical cancer screening attempts to reduce inequities in health care
access and quality of cervical cancer preventive services as well as reduce inequalities
among user groups (Finocchario-Kessler et al., 2016). As mentioned in the previous
section, WHO recommends seven essential components for service provision of cervical
cancer screening and available literature from settings similar to Swaziland will be
reviewed here. There is a dearth in the literature regarding cervical cancer screening in
HIV infected adolescent girls and what literature there is among young women is often
not disaggregated for age. There have been few studies in similar settings to Swaziland
that have evaluated the contribution of institutional system factors to the uptake of
cervical cancer screening among HIV infected AGYW, whereas there is no published
data available from Swaziland. With this study, I will attempt to provide evidence of the
relationships of specific institutional factors and the uptake of cervical cancer screening
among AGYW.
Availability of cervical cancer screening services within health facilities.
WHO defines the availability of cervical cancer screening services within the health
facility as the presence of infrastructure to offer the screening, the ability of the facility to
send specimens for cytology and receive results, an information system to monitor the
implementation of the screening and leadership within the facility to ensure continuity of
services (WHO, 2014b). In Kenya, the availability of cervical cancer screening services
in the local clinics despite the availability of the infrastructure was impacted by the lack
of management capacity within the health facilities to plan for screening services
(Huchko et al., 2011), whereas in Ethiopia, the lack of appropriate equipment and poor
infrastructure for both screening and treatment services prevented the implementation of
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cervical cancer screening within clinics (Gebreegziabher et al., 2016). Additionally, the
absence of robust communication mechanisms between the different units involved in
providing cervical cancer screening, diagnosis and treatment services (McCree et al.,
2015), inadequate health information systems to monitor the screening program and
failure of outreach programs to reach the at risk women (Fletcher et al., 2014; Kasting et
al., 2016; Randall & Ghebre, 2016b) have been shown to reduce the availability of
cervical cancer screening services.
Comprehensive screening and treatment services that are only provided in urban
clinics or hospitals limit access to these services. In a low income estate in Durban, South
Africa, HIV infected women reported a desire to have integrated services in community
clinics as this improved access for them (Ports et al., 2015). In multiple rural
communities in Nigeria, women had low knowledge of cervical cancer but were
interested in finding out more and were anxious to have the opportunity to get screened
but only if the screening was offered within their community clinics (Nwankwo,
Aniebue, Aguwa, Anarado, & Agunwah, 2011). In Canada, where opportunistic
screening has been successful except in the First Nations populations, a qualitative survey
among health providers revealed that opportunistic cervical cancer screening programs do
not perform well for First Nations women who experience significant screening-related
health inequalities that are mainly influenced by structural barriers such as inadequately
trained health care providers, lack of a recall based screening system as well as
inadequate structural access and therefore recommend integrated and systematic
screening for vulnerable populations (Maar et al., 2013). In Swaziland, HIV infected
AGYW attend HIV clinics regularly for medication refills or for HIV or sexual
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reproductive health care services including family planning. The HIV and sexual
reproductive health services are mostly integrated into primary health clinics that offer
both preventive and curative services (Church et al., 2015). These visits for HIV care can
be used as an opportunity to implement cervical cancer screening among AGYW.
However, the absence of routine cervical screening services is a missed opportunity for
prevention or early diagnosis of the disease among this high-risk population (Murillo et
al., 2016; Randall & Ghebre, 2016a; Rengaswamy Sankaranarayanan, Anorlu, SangwaLugoma, & Denny, 2013). While many researchers find that the integration of services
improves the uptake of services, there is also evidence from community-based studies
that women are just as likely to access the service if it is available within their local clinic
regardless of integration or not. Seemingly the uptake of cervical cancer screening is
influenced by the availability of infrastructure and systems to support the screening
within each clinic and not only the lack of integration of the services. Based on this
evidence and using information from the Service Availability Mapping of 2017, I will
assess the availability of cervical cancer screening services within facilities especially in
those facilities that provide HIV care and treatment where AGYW receive care.
Availability of trained health care providers. Health care workers can
significantly contribute to improvements in cervical cancer screening practices among
women as they are usually the first point of contact within the health care system
(Maseko et al., 2015c. In Uganda and Ethiopia, countries with high incidences of cervical
cancer, poor knowledge of cervical cancer and the rationale for screening as well as poor
awareness of the available screening guidelines among health care workers have
hampered the systematic implementation of cervical cancer screening (Dulla et al., 2017;
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Wanyenze et al., 2017). Assessments of public health approaches to reduce cervical and
breast cancer have shown that health care workers need be knowledgeable and skilled to
improve their compliance with the recommended practices that promote prevention
interventions for cervical cancer such as screening (Liljestrand & Sambath, 2012; Miller,
Plescia, & Ekwueme, 2014). Studies from South Africa, Zambia and Malawi, countries
with high HIV prevalence and high cervical cancer incidence have shown that training
and post training mentorship are two methods to improve health care worker knowledge
and skills regarding cervical cancer screening (McFarland, Gueldner, & Mogobe, 2016).
However, training and mentorship alone are not sufficient and health care worker attitude
that can be a main barrier to screening as it is perceived as “extra work” resulting in
missed opportunities for cervical cancer screening, needs to be addressed during training
and mentorship (Brouwers et al., 2011; Paz-Soldán, Bayer, Nussbaum, & Cabrera, 2012).
In Swaziland, with a doctor population ratio of 10 to 100,000, a nurse population ratio of
56 to 100,000 and a midwife population ratio of 64 to 100,000, provision of health care
services is a challenge and therefore the introduction of what is considered a nonessential service by the health care providers is resisted (Riley et al., 2012; Scheffler,
2012). Other public health programs in Swaziland like the Swaziland National AIDS
Program (SNAP) addressed the poor coverage of HIV treatment services by
implementing task shifting and continuous training and mentoring of health care
providers to scale up the initiation of Antiretroviral therapy in the country to successfully
achieve treatment coverage of 82% (Dlamini-Simelane & Moyer, 2017; Mdege,
Chindove, & Ali, 2013). The sexual and reproductive health program under which
cervical cancer screening lies, adapted the WHO training package on Cervical cancer
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screening and is training health care providers in clinics (Jolly et al., 2017; Malambo &
Erikson, 2017). However, the quality of the training and the continuous mentorship are
not standardized, and post training evaluations are not available to ascertain the
competency in terms of knowledge and skills of the providers to offer cervical cancer
screening to eligible women (Jolly et al., 2017). It is also not known what proportion of
health care workers who have been trained on cervical cancer screening are actually
providing the services. Using the national In-service training data base, I assessed the
number and placement of trained health care providers who are providing cervical cancer
screening. However, due to the use of secondary data that was limited in the kind of
variables, it was not possible to evaluate the skills of the trained providers within the
clinical setting or the quality of the service they are providing.
Provision of referrals for cervical cancer screening. Women value guidance
from their providers regarding what to screen for and how to get screened, and are more
likely to go if they have a provider’s referral (J. J. Kim et al., 2015; Peirson, FitzpatrickLewis, Ciliska, & Warren, 2013). The provision of referral for services ensures that both
women and health care providers are making use of available resources within the public
health sector, the women receive the care they need while the health care workers make
better use of the available resources within the health system (Wåhlberg, Valle, Malm, &
Broderstad, 2013). In most sub-Saharan countries with no guiding policies on service
provision for cervical cancer screening, unavailability of service directories and few
trained health care providers, the provision of referrals for cervical screening to women
who are eligible is opportunistic rather than routine (McFarland et al., 2016; MorhasonBello et al., 2013; Randall & Ghebre, 2016b). Evidence from Ethiopia and Malawi
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suggest that referrals are not provided routinely but if women request the service, or the
health care worker is reminded by either a job aid or a peer, or if they themselves take an
interest in cervical cancer prevention and awareness activities (Maseko et al., 2015b;
Roman et al., 2014), referrals for cervical cancer screening are provided and follow up is
made to ensure that the woman receives the service. In Swaziland, although there is a
national referral system within the health care system, the referral document is generic
and not user-friendly for health care providers and neither is there a standardized
mechanism for the flow of information to and from the sending and receiving facilities
(Macintyre et al., 2011; MacKellar et al., 2016). The health records system is paper based
and therefore there are no systematic triggers to remind the health care provider to
provide a referral for services should the facility not have the services (Macintyre et al.,
2011). A review of the referrals provided for patients who have been newly diagnosed
with HIV in Swaziland found that only 50% of patients were routinely provided with
referrals and only 30% of those were ultimately linked to HIV care (MacKellar et al.,
2016). Given that the cervical cancer screening is opportunistic, it is not known how
many of the eligible women receive referrals for cervical cancer screening and whether
those who receive a referral, are followed up appropriately. With this study, I evaluated
the proportion of AGYW in HIV clinics that did not offer cervical cancer screening who
received a referral and went on to receive the service. With this evidence, it may be
possible to describe the possible communication loops required to improve the flow of
information between sending and receiving facilities.
Differences in uptake of services between HIV-infected adolescent girls and
young women. For cervical cancer screening to be effective, asymptomatic women need
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to access the services. This is a challenge because many young people only attend health
facilities when they are unwell. Additionally, to access a service, the recipient needs to
know about the service and its benefits (Bayu et al., 2016). Prior studies have shown that
a major barrier to the uptake of cervical cancer screening is the lack of knowledge among
women and their communities (Abiodun, Olu-Abiodun, Sotunsa, & Oluwole, 2014;
Kahesa et al., 2012). Other barriers include fear of the procedure, social and cultural
norms that do not allow women to expose themselves to people other than their husbands
or talk about diseases that affect the female reproductive organs, stigma related to sexual
promiscuity and cervical cancer as well as lack of communication between the health
care workers and the recipients of care (Idowu, Olowookere, Fagbemi, & Ogunlaja, 2016;
Jain, Halder, & Mehrotra, 2016). For HIV-infected women, service uptake is hampered
by limited integration of HIV and cervical cancer prevention and treatment services as
well as stigma and discrimination (Fletcher et al., 2014). Where integration has happened,
there is limited tracking of service uptake. There is a paucity of evidence regarding
cervical cancer screening among HIV infected adolescents and young women in Southern
Africa but evidence from Europe and North America suggests that adolescents and young
women tend to be screened unnecessarily creating both management and emotional
issues for both the adolescent and the service provider (Van Kerrebroeck & Makar,
2016). However, the European population is different than that found in Swaziland or
Southern Africa in that, the proportion of adolescents with HIV are few, they can clear
off the HPV infection with very little untoward outcomes (Boardman & Robison, 2013).
Despite the recent change in guidelines that do not recommend the routine screening of
adolescents, there is a provision for the routine screening of HIV infected adolescents and
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young women due to the recognition of the increased risk of developing cancer of the
cervix (WHO, 2013). Zambia, a country with the highest cervical cancer rates in Africa at
58.4 per 100,000, has the largest and most well established cervical screening program in
Southern Africa (Parham et al., 2015). In 2017, the country reported a total of 90 cases of
cervical cancer in women aged 15 -24 years, while thirteen countries in Eastern Africa
reported a total of 901 cases in the same age group (Bruni et al., 2016). In Malawi, 35%50% of the cervical lesions detected in young women were found to be in advanced
stages and screening only took place because they were symptomatic (Maseko et al.,
2015a; Msyamboza, Phiri, Sichali, Kwenda, & Kachale, 2016b; Munthali, Ngwira, &
Taulo, 2015) Kaufman et al (2016) conducted a systematic review of voluntary male
medical circumcision in high HIV prevalence Sub-Saharan countries and found that even
in the presence of adolescent friendly services within health facilities, adolescents will
not necessarily access the available services in a timely manner. The inability to access
adolescent sexual and reproductive health services was related to provider incompetency,
lack of privacy, and limited service availability hours (Kaufman et al., 2016). The lack of
integrated HIV and sexual reproductive health service delivery points means there are
missed opportunities for the routine cervical cancer screening of HIV infected AGYW
(Fletcher et al., 2014; Setse et al., 2012). Despite great progress in the provision of HIV
services in almost all health facilities in Swaziland, the HIV program is run as a vertical
program and therefore the integration of services is inconsistent (Obure et al., 2016).
Obure et al. (2016) went on to compare the integration of HIV and sexual reproductive
health services in facilities in Kenya and Swaziland and found that in facilities where
integration had occurred, the quality of care was not any better than in non-integrated
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sites. They concluded that competent staff in adequate numbers, a robust educational
program and functional infrastructure play a greater role in delivery of adolescent health
services. Young women aged 20 -24 years have greater opportunity for cervical cancer
screening during routine family planning visits, ante- and post- natal care check-up as
well as during child welfare visits (Lyimo & Beran, 2012b). However, their uptake for
cervical screening is still poor. Research done in China, Kenya, and Nigeria show similar
findings that knowledge of cervical cancer and its prevention as well as distance from a
cervical cancer screening facility are among the main determinants of screening among
young women (Jia et al., 2013; Ndikom & Ofi, 2012; Sudenga, Rositch, Otieno, & Smith,
2013). In Swaziland, young women enter the health system during antenatal care where
they receive the first HIV test, including screening for other sexually transmitted
diseases. However, due to poor tracking and monitoring systems, there is limited data
regarding their uptake of services including cervical cancer screening (Mak et al., 2013;
Tsawe et al., 2015). It would seem from the review of the literature, that the factors that
prevented young women (20-24 years) from accessing cervical cancer screening are
slightly different than those affecting adolescent girls (15-19 years) and in the context of
Swaziland needed to be investigated further to inform the programming of cervical
cancer screening services given the growing population of HIV infected AGYW. I
reviewed the data to compare the uptake of cervical cancer screening between AG and
YW and described any differences.
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Definitions
Adolescent girls and young women (AGYW): Descriptor term for young women
who lie between the ages of 15 and 24 years. AG are those who fall between 15 and 18
years and YW fall between 19 and 24 years (Dellar et al., 2015).
High at-risk population: Subpopulations who are at an increased for a specific
negative health outcome (Howard & Sacco, 2009).
Availability of cervical cancer screening in facilities: The WHO provides criteria
to define availability of cervical cancer screening at a health facility. The criteria include
the presence of infrastructure to offer the screening, the ability of the facility to send
specimens for cytology and receive results, an information system to monitor the
implementation of the screening and leadership within the facility to ensure continuity of
services (WHO, 2014b).
Trained health care providers: Health care providers who receive a mandated or
government approved skills or knowledge building intervention (Ameh & Van Den
Broek, 2015).
Referral system: a formal mechanism that allows a client to receive a service
elsewhere and the mechanism allows for tracking of the client (Gulati & Penn, 2014).
Assumptions
The assumption was that all AGYW who were accessing HIV care and treatment
would have had equal opportunity to hear about cervical cancer screening and that their
knowledge and attitudes permitted them to participate in preventive care. However, their
attitudes and perceptions may have prevented them from participating in cervical cancer
screening despite the availability of all health care components. The other assumption
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was that all health facilities that had the infrastructure for cervical cancer screening were
promoting the services and all health care providers who had received training on
cervical cancer screening would provide the services. In reality, not all facilities with the
infrastructure for cervical cancer screening were promoting the service and not all trained
health care providers were providing the screening services. The assumptions were
necessary to make because the exploration of these institutional factors would highlight
the factors that play a role in the uptake of cervical cancer screening in the target
population. Secondary data were used in this study and was assumed to be valid and
reliable because the data were collected using established measures that had been
validated by the Strategic Information Department in the Ministry of Health and the data
contained enough samples to provide a representation of the broader population.
Scope and Delimitations
This study extended only to HIV infected AGYW in Swaziland and therefore may
not be generalizable to non- HIV infected AGYW in Swaziland and HIV infected
AGYW in other settings whose public health systems may be unlike that of Swaziland. 1
acknowledge that although there are other contributors to the uptake of cervical cancer
such as educational level, knowledge of the AGYW, attitudes of the community and the
AGYW towards cancer screening, culture and health seeking behaviors this study was
delimited to the exploration of specific institutional (health services) factors that affect
the uptake of cervical cancer screening among AGYW. The exploration of institutional
factors is not all encompassing, and I only examined the availability of screening
services, trained health care providers, the provision of referrals for cervical cancer
screening and the difference in uptake between AG and YW. The choice of institutional
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factors was determined by the available variables in the datasets from which the study
data were extracted. The use of retrospective secondary quantitative data whose quality at
collection could not be guaranteed may have affected the study outcomes. Additionally, it
was not possible to interrogate the data in depth because the interrogation was limited by
the quantitative nature of the study.
Significance, Summary and Conclusions
Although it is two years since the National declaration on prioritization of cervical
screening, little implementation has happened within the health care facilities in
Swaziland. The Sexual Reproductive Health Unit with funding from Bristol Myers
Squibbs Foundation developed an action plan to provide basic equipment to conduct the
screening tests and train health care providers to use the equipment (Jolly et al., 2017).
However, this funding has not yet translated into effective program implementation, there
is no uniformity in level of provision of cervical cancer screening across the regions let
alone within the same region and the outcomes of these activities are not yet evaluated
especially among adolescent girls and young women who are a vulnerable population
requiring strong prevention efforts (Church et al., 2015). These issues highlight the need
for mainstreaming cervical cancer screening programs within the public health system.
To curtail excessive expenditure on infrastructure and in view of the high HIV prevalence
in this country (32%), cervical cancer screening services in this country should preferably
be population based, systematic and integrated within primary care clinics and leveraging
existing infrastructure for provision of screening (Church et al., 2015; Parham et al.,
2015). This literature review summarized some of the available evidence on the system
barriers to cervical cancer screening among women and when available on AGYW to
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provide a context for the analysis of the situation in Swaziland. I reviewed the available
data to describe the health system determinants of cervical cancer screening among HIV
infected AGYW whose treatment outcomes impact negatively on themselves, the HIV
and Sexual and Reproductive Health Unit program performance and the communities
within which they live. The results of the study may be used to inform public health
programming within this population to improve cervical cancer screening and reduce
both the morbidity and mortality associated with this cancer in this population.
This study was important because it focused on cervical cancer screening among a
high-risk population in Swaziland. Early detection of cervical cancer in this group will
provide an opportunity for early treatment thereby reducing morbidity and premature
mortality and associated elevated health care costs (Hung, Liu, Cheng, & Wang, 2014). I
sought to identify gaps in the health care inputs that affect the uptake of cervical cancer
screening. The contribution of this study to the current limited literature regarding
cervical cancer screening in Swaziland was to provide additional evidence regarding the
determinants of cervical cancer screening in high risk young women. The findings may
generate additional questions that will form the basis for more research. The sexual
reproductive health program of the Ministry of Health can use the findings to improve
cervical screening services within the country. Public health practitioners can also use the
significant findings to inform health promotion and education programs for both health
care workers and clients, as well as policy guidelines to inform screening
recommendations.
Young women are the backbone of many communities in Swaziland as the men
migrate looking for work and therefore are responsible for both social and economic
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growth in their communities (Brixiová & Kangoye, 2016). If they are affected by cervical
cancer for which there is limited treatment, communities will suffer as will the children
and the elderly who these women take care of (Hajizadeh, Sia, Heymann, & Nandi,
2014). This study could contribute to positive social change by responding to the
Swaziland National Health Policy 2015-2020 goal to reduce the incidence of cancer
deaths through improvements in the equitable and accessible delivery of health services
for priority populations like adolescent girls and young women (Swaziland Ministry of
Health, 2015a).
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Section 2: Research Design and Data Collection
Introduction
HIV-infected young Swazi women are at increased risk of cervical cancer because
of their low participation in preventative screening programs and their HIV infection
(Swaziland Ministry of Health, 2015c). Cervical cancer is a major contributor of
morbidity and mortality among Swazi women and especially HIV-infected young women
(Information Centre on HPV and Associated Cancers, 2016; Swaziland Ministry of
Health, 2016). The purpose of this study was to examine the relationships between health
care institutional factors and the uptake of cervical cancer screening among HIV-infected
AGYW to inform policy and interventions to reduce morbidity and mortality related to
this disease. In this section, I describe the research design and the rationale and the
conduct of the research including data
Research Design and Rationale
The overall design of my study was a quantitative approach, as I used secondary
data extracted from the Swaziland Ministry of Health’s HMIS to answer the research
questions (see Creswell, 2014). I also used a correlational cross-sectional study design to
explore the relationships between health care institutional factors and the uptake of
cervical cancer screening among HIV-infected AGYW in Swaziland. A cross-sectional
design was deemed appropriate because the intention of this research was to determine
the empirical relationship between the independent and dependent variables and not
determine causation (Sedgwick, 2014a). The study methods did not include the
observation or interviewing of participants but rather the examination of routine data
from surveys, making this study also retrospective in nature (Sedgwick, 2014b). The
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factors that were investigated included the availability of cervical cancer screening
services in clinics, the presence of trained health care providers, the availability of
referral systems for screening, and the age of the women. Other covariates included
location of the clinic and ownership of the clinic.
Independent variables. The independent health care institutional factors that I
investigated included:
•

The availability of cervical cancer screening services in a facility, that was
defined as the facility having the infrastructure to conduct the screening, the
mechanisms to obtain pathology results of the screening test, and the systems to
feedback to the patient to trigger appropriate health seeking behaviors (WHO,
2013)

•

The presence of trained health care workers within the facility that was defined as
a health care worker who has undergone an accredited training on cervical cancer
screening and is recognized by the Sexual and Reproductive Health Unit as being
a trained provider

•

The provision of referrals for cervical cancer screening to eligible women, that
encompassed a health care provider referring an eligible woman for cervical
cancer screening and documenting the referral as well as the outcome of the
referral in the patient record (Miller, Hanson, et al., 2014)

•

Although not an institutional factor, I also examined the difference in uptake of
cervical cancer screening between HIV-infected adolescent girls and HIVinfected young women.
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Dependent variable. There was only one dependent variable for the study, that
was the uptake of cervical cancer screening. This was defined as the acceptance, seeking
out, and receipt of cervical cancer screening in an eligible woman or women (Mwaniki et
al., 2014).
Additional factors that were assessed included locality of the clinic (rural or
urban) and ownership of the facility. These were categorized as government owned,
missionary owned, private for profit, and private not for profit, as these may have played
a role in the availability of the cancer screening services in a clinic.
Rationale for Secondary Data Analysis
Secondary data analysis is a valid research design that requires the rigor
demanded of primary data analysis research designs, that consists of the researcher
collecting, analyzing, and interpreting data (Johnston, 2014). Similarly, in secondary data
analysis there are procedural and evaluative steps: the researcher is required to develop
research questions, identify potential datasets, and then evaluate the dataset to ensure it
can answer the research questions (Johnston, 2014; Koziol & Arthur, 2012). Fundamental
to secondary data analysis is the application of theoretical knowledge and conceptual
skills to use existing data to address the research questions (Cheng & Phillips, 2014).
Advantages of secondary data analysis. The advantages associated with
secondary analysis are the timeliness of production of results, cost effectiveness, and
convenience it provides as minimal financial resources have to be allocated to the data
collection processes (Johnston, 2014). The availability of quality secondary data allows
researchers to access and use datasets that have larger sample populations that are more
representative of the target population, that allows for more generalizable findings and
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increased validity (Windle, 2010). Secondary data analysis also presents opportunities to
conduct research and allows for building capacity for empirical research (Cheng &
Phillips, 2014). Finally, using secondary data allows research studies to be completed
quicker and results produced in a timely manner to inform policy and practice (Goodwin,
2012).
Disadvantages of secondary data analysis. Despite the advantages, there are
disadvantages to using secondary data. The most common limitation is inherent to the use
of secondary data in that the data were collected for another purpose and may not provide
adequate or in-depth data that the researcher requires, limiting the location of study, the
population, or even the variables (Schlomer & Copp, 2014). Another limitation is that the
researcher using secondary data cannot guarantee the quality of the data that were
collected. The researcher can review the data collection and validation processes but
cannot correct the inadequacies of the data and therefore these will become inherent
limitations or causes of bias to the secondary data analysis.
Methodology
Population
The population that I studied were HIV-infected young women between the ages
of 15 and 24 attending HIV care clinics in Swaziland. The young women were further
disaggregated into adolescent girls aged 15–18 and young women 19–24. This population
makes up 10.4% of the total population in Swaziland, that has the second highest HIV
incidence rate of 1.87 and accounts for 14 % of the HIV-infected population in
Swaziland. There were 185 HIV care and treatment clinics in the country, and there were
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12,329 HIV-infected AGYW enrolled in care by the end of March 2018. The population
under study was drawn from these HIV care clinics.
Data Set
I used routinely collected data for my study that was provided by the Ministry of
Health’s HMIS unit that aggregates all facility level data at the national level. For this
study, I used data from the HIV care clinics collected until March 2018, the training
information management system, and the SARA 2017. The HMIS unit provided a
semimerged set of data that included a listing of AGYW per facility and included a
system generated unique identifier or serial number (this number is generated whenever
the data is requested and is not a personal identification number), date of birth, treatment
regimen, and referrals or future appointments for screening services as well as other care
services clients receive such as tuberculosis screening and cervical cancer screening. The
training information management system collects information on the type of training, the
facilities that received the training and the number of nurses from each facility that were
trained. A list was generated from the training information management system that
provided each facility with number and cadre of provider who have been trained and
certified to provide cervical cancer screening. The SARA 2017 is a comprehensive
survey database that provided a listing of facilities that provide HIV care services to
AGYW and their characteristics such as the presence of cervical cancer screening,
location of the clinic, and ownership of the clinic.
To achieve the data set I needed to answer my research questions, I merged the
patient level dataset and the SARA dataset into one dataset. The common variable was
the facility unique identifier. All routinely collected data undergoes validation during

45
quarterly routine data quality audits that are conducted by the HMIS unit. As per the
national data management guidelines, all facilities are required to conduct data quality
checks, prior to submitting their quarterly reports (HMIS, n.d.). These procedures ensured
that the data that was collected and deposited within the HMIS unit meets a certain
quality standard and therefore improved the validity of this study.
The SARA 2017 data are available on the government website and required no
specific permission to use. However, for the HIV care and treatment data and the health
care provider training data, permission was sought from the HMIS unit. To be able to
disseminate the research findings, I made a formal request to the National Health
Research Review Board once the proposal was approved by Walden University.
Sampling Procedures Used to Collect Data
In the study, I employed total population sampling that is a type of purposive
sampling (Laerd Dissertation, 2012; Wu Suen, Huang, & Lee, 2014). This is because the
HIV-infected AGYW were a relatively small population in comparison to the rest of the
people living with HIV attending HIV care clinics in Swaziland (only 14%). All facilities
providing HIV care to the target population were included in the sample. There was no
set number of AGYW in each health facility; therefore, all HIV-infected AGYW enrolled
in these facilities were included in the study. The minimum sample size to adequately
power the study was calculated to ensure that the number of AGYW in the data set met
this minimum number and informed the interpretation of the results. The use of purposive
sampling in my study affected the generalizability of the results (Parker, 2013). However,
total population sampling ensured that all eligible AGYW in the target population were
included in the study and enabled some analytical generalizations about the target
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population (Laerd Dissertation, 2012). The disadvantage with total population sampling
is that all people in the target group need to be included in the sampling frame and if they
are not, an important characteristic may not be investigated (Parker, 2013).
Sampling Frame
A list of all health facilities that offer HIV care services in each of the regions in
the country was obtained from the SARA 2017 and used as the sampling frame for the
study. The health facilities were disaggregated according to level of care provided:
primary health clinics, health centers, and regional or referral hospitals as well as the
region in which they were located. To ensure completeness of the sampling frame, I
consulted with the Swaziland National AIDS Program to confirm that all HIV care clinics
by region were included (see Table 1).
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Table 1
Health Facilities in Swaziland that Provide HIV care by Region
Region

Primary Health Clinics

Health Centers

Hospitals

Shiselweni

19

2

1

Hhohho

48

2

4

Manzini

66

0

4

Lubombo

37

1

1

Total

170

5

10

Primary health clinics make up 92% of all health facilities that offer HIV care.
Health centers make up 2.6% of all health facilities providing HIV care and treatment
services. Because health centers offer more services than the primary health clinics and
have at least one doctor available, they tend to have more patients, especially children
and adolescents, than the primary health clinics. Hospitals account for only 5.4% of all
health facilities in Swaziland; however, they were the first institutions to offer HIV care
and also provide management of treatment experienced patients and the vulnerable
populations under which the AGYW fall. Thus, the total number of facilities that provide
the sample of AGYW were 170 primary health clinics, five health centers, and 10
hospitals, making a total of 185 health facilities.
Use of the sampling frame to obtain the sample size. Once all the HIV care
clinics were verified by the National AIDS Program, data from these facilities were
requested from the HMIS and the data pertaining to the target population of AGYW were
extracted. Given that there was no set number of HIV infected AGYW per health facility
and their distribution across the different types of health facilities was varied, all AGYW
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in each facility were included in the sample population. The use of all AGYW in the
sample population increased the generalization of the results. Because the sample size
was predetermined, this affected the power of the study to detect significant differences
between the independent and dependent variables. A power analysis requires an effect
size that is usually determined after the data collection and analysis (Ryan, 2013).
There is a lack of literature regarding institutional factors that impact on the
uptake of cervical cancer screening among AGYW for me to have been able to reference
an effect size to estimate the power of the study. Therefore, I conducted a post hoc power
analysis to calculate the power and compared it with the one I estimated using an effect
size value of 0.3 as it indicated a medium to large difference. I used the software
G*Power 3.1.9.2 to compute the power analysis for sample size. I chose to use the χ² test
because I wanted to examine the relationship between nominal level categorical variables
(Simpson, 2015). The margin of error chosen for the study was 5% with a 95% level of
confidence. The analysis was a priori to compute a minimum sample size and power of
the study. The output is as follows:
Input: Effect size w = 0.3
α err prob = 0.05
Power (1-β err prob) = 0.95
Df = 1
Output: Non-centrality parameter λ = 13.0500000
Critical χ² = 3.8414588
Total sample size = 145
Actual power = 0.9507851
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Based on this computation, a minimum sample size of 145 AGYW was required to
achieve at least 95% chance of being able to detect a 30% effect size of the relationship
between the independent and dependent variables.
I conducted the post hoc power analysis for a one sample study with a
dichotomous end point using the uptake of cervical cancer screening among the
population of 33%, the uptake of cervical cancer screening among the study population of
20.45%, the study population of 10,618 and an alpha level of 0.05 resulting in a post-hoc
power of 100%. Figure 1 illustrates the calculation for the post-hoc power analysis.

Figure 1: Post hoc Power analysis

Inclusion and Exclusion Criteria
All health facilities providing HIV care services were eligible to be included in
this study. HIV care clinics that did not have any HIV infected AGYW enrolled in care
were excluded from the analysis. Facilities with HIV care clinics that had not submitted
quarterly data reports to the HMIS consistently over the two years 2016-2017 were also
excluded because their data were incomplete. This exclusion criteria were included to
ensure that only recent and updated data were used in the study.
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The inclusion criteria for the study population were the AGYW aged between 15
and 24 years who have been diagnosed HIV positive and enrolled in HIV care. These
AGYW should have been in care for at least two years to allow enough time within the
clinic for the AGYW to receive at least one cervical cancer screening. All HIV positive
AGYW who had been enrolled in the HIV clinic less than one year were excluded from
the study.
Instrumentation and Operationalization of Constructs
The measuring instrument I used was in the form of a questionnaire. The
questionnaire was a set of structured questions that was used to obtain and aggregate the
data from the secondary dataset to answer the research questions without the need to
interview the target population (Timmins, 2015). I selected the questionnaire method as
the data collecting methodology because it made the quantification of information
possible (Aitrs, 2012). Questionnaires can be used to diagnose institutional functioning
(Liamputtong, 2013); however, the construction of a questionnaire is complex because
every question or item must be formulated carefully based on the research questions
(Rowley, 2014). The questionnaire can be extracted from service standards or guidance
documents for consistency and validity (Govender, Mabuza, Ogunbanjo, & Mash, 2014).
The questions that I used to interrogate the availability of cervical cancer screening
services was informed by the WHO guidance on Cervical Cancer Screening programs
(WHO, 2013). Other researchers who have conducted studies that investigated the
systemic factors affecting uptake of cervical cancer screening have used the WHO
guidance on Cervical Cancer Screening Programs as the basis for the development of
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their tools (Akinyemiju, McDonald, & Lantz, 2015; Campos et al., 2015; R.
Sankaranarayanan, 2014).
Operationalization. The main variables are defined in Table 2.

52
Table 2
Definitions of Variables
Research
Question
Facility
characteristics

Variable

Data Source

Definition

Measurement

Facility type

Service
Availability
Mapping

Categorical: single
response out of three
options

Facility
Location

Service
Availability
Mapping

There are three
categories depending on
services provided:
Primary Health Clinic,
Health Centre, or
Hospital
Classification of location
of the facility as either
rural or urban

Facility unique
identifier

Service
Availability
Mapping
Service
Availability
Mapping
Service
Availability
Mapping

How often are
services
provided

Service
Availability
Mapping

Number that is assigned
to the facility by the
ministry
Facility can be owned by
private, government or
mission entities
Facility meets the
criteria for providing
cervical cancer screening
services including
equipment to conduct
screening, in-service
communication and
mechanism to examine
samples and provide
results to the clients
Number of days per
week that cervical cancer
screening is offered

Does facility
advertise
cervical cancer
screening
services

Service
Availability
Mapping

Signage at the facility
that advertises cervical
cancer screening services

Facility
Ownership
Facility has
cervical cancer
screening
services

Categorical with two
options - single
response out of two
options that include
rural location of clinic
or urban location of
clinic
Categorical because
this variable is
alphanumeric.
Categorical: single
response out of three
options
Nominal: Yes, facility
has cervical cancer
services or No, facility
does not have cervical
cancer screening
services

Categorical: single
response out of three
options. The number
of times services are
provided will be
classified as 0, 1-3, >3
Nominal: the response
is either a yes, services
are advertised or no,
services are not
advertised

(table continues)
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Research
Question

Variable

Data Source

Definition

Measurement

Participant
characteristics

Date of
birth/age at last
birthday
Date of
enrollment into
HIV care

HMIS

Date of birth recorded
in register of AGYW

Continuous (number of
years)

HMIS

Date that AGYW was
registered for HIV care

Number of
years AGYW
has been in HIV
care
HIV treatment
start date

HMIS

Length of time that the
AGYW has been
enrolled in HIV care

Categorical (date): the
date will be used to
calculate number of
years that the client has
been enrolled in HIV
care
Continuous

HMIS

Date that AGYW was
started on HIV
treatment

Number of
years AGYW
has been on
HIV treatment
Eligible for
cervical cancer
screening

HMIS

Length of time in years
that AGYW has been
on HIV treatment

HMIS

Received
Cervical cancer
screening

HMIS

AGYW has been
diagnosed with HIV at
least 12 months and
should receive a
cervical cancer
screening as per HIV
management guidelines
AGYW has undergone
cervical cancer
screening in the last 12
months.

Received
cervical cancer
screening
within the last
12 months
Results of
screening
documented

HMIS

Proportion of eligible
AGYW that received a
cervical cancer screen
during 2016 - 2017

HMIS

Results of the screening
available in the register

Uptake of
cervical cancer
screening
(calculated)

Categorical (date): the
date will be used to
calculate number of
years that the client has
been on HIV treatment
Continuous

Categorical: the
responses include either
yes, eligible for
screening or no, not
eligible for screening.
Categorical: the
responses include either
yes, has received
cervical cancer
screening or no, has not
received cervical cancer
screening.
Proportion or
percentage of AGYW
who were eligible for
screening and then
received the screening
Nominal: either
responds as yes,
screening results are
documented or no,
screening results not
documented

(table continues)
Research Question

Variable

Data
Source

Definition

Measurement
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What is the relationship
between the availability
of trained health
providers and the
uptake of cervical
cancer screening among
HIV-positive
adolescent girls and
young women in
Swaziland?
What is the relationship
between the availability
of cervical cancer
screening services in a
facility and the uptake
of cervical cancer
screening among HIVpositive adolescent girls
and young women in
Swaziland?

Does facility
have trained
cervical
cancer
screening
providers?
Number of
providers
Facility has
cervical
cancer
screening
services

Training
Information
Manageme
nt System
Training
Information
Manageme
nt System
Service
Availability
Mapping

The facility has
providers who have
undergone
accredited cervical
cancer screening
training
Count of trained
providers per
facility

Nominal: response is
either yes, trained
providers are available
or no, there are no
trained providers
available
Continuous (number of
trainers)

Facility meets the
criteria for
providing cervical
cancer screening
services including
equipment to
conduct screening,
in-service
communication and
mechanism to
examine samples
and provide results
to the clients
Number of days per
week that cervical
cancer screening is
offered

Nominal: Yes, facility
has cervical cancer
services or No, facility
does not have cervical
cancer screening
services

How often
are services
provided

Service
Availability
Mapping

Does facility
advertise
cervical
cancer
screening
services
AGYW who
received
cervical
cancer
screening

Service
Availability
Mapping

Signage at the
facility that
advertises cervical
cancer screening
services

HMIS

Count of number of
AGYW who
received cervical
cancer screening

Categorical: single
response out of three
options. The number of
times services are
provided will be
classified as 0, 1-3, >3
Nominal: the response
is either a yes, services
are advertised or no,
services are not
advertised
Continuous variable
(number of AGYW)

(table continues)
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Research Question

Variable

Data
Source

Definition

Measurement

What is the relationship
between the provision
of a referral for cervical
cancer screening among
eligible women and the
uptake of cervical
cancer screening among
HIV-positive
adolescent girls and
young women in
Swaziland?
Is there a difference in
uptake of cervical
cancer screening
between HIV-positive
adolescent girls and
HIV-positive young
women?

Was referral
documented?

HMIS

Nominal: Yes patient
was provided a referral
or No patient was not
provided with a referral

Were
appropriate
referrals
provided to
client

HMIS

Patient provided
with referral for next
service is
documented in the
register/EMR
If referral is
documented, was it
appropriate as
determined by the
need of the client.

Uptake of
cervical
cancer
screening
disaggregated
by AG and
YW.
Age group to
differentiate
AG and YW

within
study
dataset

proportion of
eligible AGYW who
received a cervical
cancer screen during
2016-2017 per age
group

Continuous
(proportion)

within
study
dataset

study participants
will be grouped into
15 to 19 years old
and 20 - 24 years

Categorical

Nominal: Yes
appropriate referral was
provided, No,
inappropriate referral
was provided

Data Analysis Plan
The data analysis plan articulates how the data were cleaned, transformed, and
analyzed (Banks, Paige, & Mather, 2013; Michener, 2015). The data analysis plan is a
roadmap for how the data were managed and the data analysis conducted. SPSS v25 was
used to conduct the data analysis.
Cleaning the Data
Data cleaning is the removal of outliers, dealing with missing data and assessing
for normality to determine the need for data transformations (Chu, Ilyas, Krishnan, &
Wang, 2016).
Outliers. All the variables measured on a continuous scale like age, length of
time the AGYW has been in HIV care and length of time the AGYW has been on HIV
treatment was assessed for outliers. If an observation had a standard deviation of greater
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than ±3.29 from the variable’s mean, it was considered as an outlier (Aguinis,
Gottfredson, & Joo, 2013). This was accomplished by standardizing the scores of the
variable (the variable’s scores have a mean of zero and a standard deviation of 1) and
looking for an observation greater than ±3.29 (Aguinis et al., 2013).
Missing data. Missing data is the absence of an observation on a variable.
Handling missing data may be especially challenging when using secondary datasets and
is necessary to reduce bias and enable the valid deduction of results (Palmer & Royall,
2010). Missing data may threaten statistical power by reducing sample size or, in more
extreme situations, estimates derived by deleting cases with missing values may be
biased, particularly if the cases with missing values are systematically different from
those with complete data (Kaiser, 2014). There are many ways to deal with missing data
and the selection of an appropriate remedy is determined by the percentage of missing
data and the importance of the variable in the study (Dohoo, 2015; Groenwold, Donders,
Roes, Harrell, & Moons, 2012). When missing data is less than 10%, it is acceptable to
drop the observation, however, if larger proportions are missing, the re-weighting of the
variable or multiple imputation are more appropriate choices (Osborne, 2013). Using
SPSS, I generated frequency tables for all the variables to determine the proportions of
missing data. If the missing data were less than 10%, the events would have been
dropped if determined not to adversely affect the results of the study by running the
statistical tests with and without the missing data (Dong & Peng, 2013; Howell, 2015).
However, there were no missing data.
Normality. Majority of the parametric tests have the assumption of Normality.
Normality refers to the shape of the distribution of scores (e.g., shape of a normal bell
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curve) (Ghasemi & Zahediasl, 2012). I assessed for normality by examining the skewness
and kurtosis of each continuous variable (age and length of time on treatment) using
SPSS. The data approximated the normal distribution, and no further manipulation was
done. However, had the data not been normally distributed, a transformation of the data
may have been required. Some common transformations are the square root, logarithmic,
and inverse.
Specific Statistical Tests to Examine Each of the Research Questions
The research questions enabled the description of the relationship between the
selected health care institutional factors and the uptake of cervical cancer screening
among the target population.
Research Question 1: What is the relationship between the availability of trained
health providers and the uptake of cervical cancer screening among HIV-positive
adolescent girls and young women in Swaziland?
H01: There is no relationship between the availability of trained health care
providers and the rate of uptake of cervical cancer screening among HIV-positive
adolescent girls and young women.
Ha1: There is a relationship between the availability of trained health care
providers and the uptake of cervical cancer screening among HIV-positive adolescent
girls and young women.
Research Question 2: What is the relationship between the availability of cervical
cancer screening services in a facility and the uptake of cervical cancer screening among
HIV-positive adolescent girls and young women in Swaziland?
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H02: There is no relationship between the availability of cancer screening services
within a facility and the uptake of cervical cancer screening.
Ha2: There is a relationship between the availability of cervical cancer screening
services within a facility and the uptake of cervical cancer screening.
Research Question 3: What is the relationship between the provision of a referral
for cervical cancer screening among eligible HIV positive adolescent girls and young
women and the uptake of cervical cancer screening among HIV-positive adolescent girls
and young women in Swaziland?
H03: There is no relationship between the provision of a referral for cervical
cancer screening in eligible women and the uptake of cervical cancer screening.
Ha3: There is a relationship between the provision of a referral for cervical cancer
screening in eligible women and the uptake of cervical cancer screening.
Research Question 4: Is there a difference in uptake of cervical cancer screening
between HIV-positive adolescent girls and HIV-positive young women?
H04: There is no difference in uptake of cervical cancer screening between HIVpositive adolescent girls and HIV-positive young women.
Ha4: There is a difference in uptake of cervical cancer screening between HIVpositive adolescent girls and HIV-positive young women.
Data Analysis
The selection of the statistical analysis is based on two things: the way the
hypothesis is stated in statistical language and the level of measurement of the variables
(Karran, Moodie, & Wallace, 2015). To examine the research questions, that were
examining the relationship between independent variables and a dichotomous outcome, a
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chi-square analysis was conducted. For ordinal level variables, the Cochran-Armitage
test of trend was performed (Wellek & Ziegler, 2012).
When examining the influence of one variable on another and the dependent
variable is dichotomous, then a logistic regression is the appropriate test to use, if there
are more than one categorical independent variables and the dependent variable is also
categorical, the appropriate test to use is a bivariate logistic regression and the linear
regression is the correct analysis if the dependent variable is interval level (Kasza &
Wolfe, 2014).
Univariable analysis. An analysis was conducted to describe the characteristics
of the population as well as determine the frequency of the outcome. The characteristics
of the population were described by person, and place and illustrated as frequencies.
Stratified frequencies were calculated across the age sub-groups. Further analysis was
conducted to describe the frequency distribution of the outcome variable and a
confidence interval for the prevalence estimate. Frequencies were used to describe the
categorical data and histograms were used to visualize the continuous variables
(Humphrey, Taylor, & Mittag, 2014; Weissgerber, Milic, Winham, & Garovic, 2015).
Bivariable analysis. Data to answer each of the research questions were
displayed in two variable tables. Two variable tables were used to determine whether
uptake of cervical cancer screening varied by age group. Two variable tables were also
used to quantify the associations between the independent variables and the outcome
variable with the rows representing the different levels of exposure and the columns
representing absence or presence of the outcomes.
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Calculating Measures of association. Measures of association were computed
and interpreted for the associations between the independent variables and the outcome.
Calculating Statistical Significance. Given that my research questions were
testing the relationship of the independent variable that was categorical to the dependent
variable that had a dichotomous outcome, I used a Chi Square analysis. The chi-square is
an appropriate statistical test when the purpose of the research is to examine the
relationship between two nominal level categorical variables (Mchugh, 2013). I
compared the calculated chi-square coefficient (χ2) and the critical value coefficient to
evaluate the significance of the results. When the calculated value was larger than the
critical value, with alpha of .050, the null hypothesis was rejected (suggesting a
significant relationship) (Sharpe, 2015). The alpha value also known as the significance
level is the probability of rejecting the null hypothesis when the null hypothesis is
actually true (Krzywinski & Altman, 2013). The alpha value for this study was set at 0.05
or a five percent probability of rejecting the null hypothesis when it is true. In order to
determine the degrees of freedom for a chi-square, it was necessary to use the following
equation:
df = (r – 1)(c – 1)
The r value equals the number of rows, and the c value equals the number of
columns. In order for a chi-square to run correctly, several conditions and assumptions
must be met: the data must be random samples of multinomial mutually exclusive
distribution and the expected frequencies should not be too small (Mchugh, 2013). As a
precautionary measure in chi-square examination, the expected frequencies below five
should not account for more than 20% of the cells, and there should be no cells with an
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expected frequency of less than one. If the expected cell frequencies were less than 5,
Yates continuity correction or Fisher’s exact test was used to test for significance (if it is
a 2x2 chi square), as it is a more conservative statistic (Connelly, 2016). For the ordinal
level variables, a Cochran-Armitage test of trend was conducted and to compare two
proportions, the test of two proportions was conducted (Wellek & Ziegler, 2012). The
Cochran-Armitage test of trend otherwise known as the Chi Square test of trend was used
to assess for the presence of an association between a binomial outcome variable with an
independent ordinal variable with K categories, where K is any number more than two
(Zhou, Ku, Huang, Xing, & Xing, 2017).
Assessing for effect measure modification. An effect size or effects measure was
calculated for all significant tests. The Effect size is a simple way of quantifying the
difference between two groups (Fritz, Morris, & Richler, 2012; G. M. Sullivan & Feinn,
2012). It emphasizes the size of the difference and how it relates to the general
population. It suggests the clinical or “real world” relevance of the findings of the
research. Usually, the effect size is agreed upon a priori so that a sample size can be
calculated to adequately power the study. Phi φ is a measure of effect size and is
equivalent to the correlation coefficient r (Bosco, Aguinis, Singh, Field, & Pierce, 2015;
Kelley & Preacher, 2012). It is used when the variables are categorical. Phi is defined by
the formula:

where n = the number of observations. A value of .1 is considered a small effect, .3 a
medium effect and .5 a large effect (Lakens, 2013).
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Assessing the effect of potential confounders. Confounding is an apparent
association between the population and the outcome in this case the uptake of cervical
cancer screening that results from a third factor that has not been considered in the
relationship (Creswell, 2014). A confounder is an independent risk factor for the outcome
and also happens to be associated with the independent variable or variables under
investigation.
Conducting multivariable analysis. A multivariable analysis and modeling
technique was conducted to address the hypotheses in the research questions. The results
from the bivariable analysis informed the modeling technique to determine the final
model or set of models that best described the data, as all statistically significant
relationships needed to be included in the model (Connolly, 2011; Soley-Bori, 2013)., I
used multivariable logistic regression to examine the relationship between the dependent
variable that had a dichotomous outcome and the independent or predictor variables. The
multivariable regression analysis model helped me understand how the typical value of
the dependent variable (uptake of cervical cancer screening) changes when any one of the
independent variables is varied (for example or presence of diagnostics), while the other
independent variables are static. The dependent variable in my study was the uptake of
cervical cancer screening and the independent variables included the presence of trained
providers, availability of cervical cancer screening services within an HIV clinic,
provision of a referral for appropriate services, and age group of the client. The
multivariable logistic regression allowed me to predict values of the dependent / outcome
variable for a specific independent variable as well as suggesting which independent
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variables had a major effect on the dependent/ outcome variable. (Sperandei, 2014). In
research question 1, the outcome variable was uptake of cervical cancer screening while
the predictor variable was trained health care providers whose impact on uptake was
assessed in the presence of other factors such as age group availability of referral
services, and availability of cervical cancer screening services. In research question 2, the
outcome variable was uptake of cervical cancer screening while the predictor variable
was the availability of cervical cancer screening services in facilities whose impact on the
uptake was assessed in the presence of availability of trained health care providers, age
group and availability of referral services. In research question 3, the outcome variable
was the uptake of cervical cancer screening services while the predictor variable was the
availability of referral services whose impact on uptake was assessed in the presence of
trained health care providers, age group and availability of cervical cancer screening
services in facilities. In research question 4, the outcome variable was the uptake of
cervical screening while the predictor variable was age group whose impact on uptake
was assessed in the presence of other factors such as trained health care providers,
availability of cervical cancer screening services and availability of referral systems.
Other confounding variables that were put into each of these models included the location
of the facility, facility ownership, and mean length of time the AGYW has been on
antiretroviral therapy. In the analysis, the data were examined to see if it meets the
assumptions of normal distribution, absence of multicollinearity, homoscedasticity,
independence of observations, and linearity between the dependent and independent
variables, prior to running the multivariable analysis.
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Threats to Validity
External Validity
In quantitative research, external validity is important because as researchers, the
conclusions we make from our studies should ideally be applicable to a wider population
than the sample we studied (Matt, Brewer, & Sklar, 2010). These results can ideally be
generalized to a larger population from which the sample was obtained or can be
generalized to other populations or settings or time frames. External validity asks the
question: To what extent can our conclusions be generalized to a wider population. No
study can be completely externally valid. To assess the extent to which generalizations
can be made, we have to determine how well the study sample represents the wider
population (Polit & Beck, 2010; Yin, 2013). The extent to which study results
are robust across different populations and settings varies according to the research
paradigm (i.e., a positivist versus a post-positivist research paradigm). Positivists tend to
build grander theories and therefore make broader generalizations from the results while
Post-Positivists are less likely to have expansionist theories and make conservative
generalizations. The various research designs (descriptive, quasi-experimental,
experimental) also affect the external validity of the study conclusions (Banerjee,
Chassang, & Snowberg, 2016).
Threats to external validity are any factors within a study that reduce the
generalizability of the results of which there are a wide range including (a) selection
bias; (b) threats due to the constructs, methods and confounding that has not been
adjusted for; (c) the 'real world' versus the 'experimental world'; and (d) history effects
and maturation.
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Selection bias. People differ along a wide range of factors that are inherent to the
person, such as age, gender, height, intelligence, attitude, behavior. When the sample that
is studied does not represent the population from which the sample was selected, there
has been a selection bias (Pearce & Richiardi, 2014; Westreich, 2012). Where selection
bias occurs, it is challenging to argue that the results can be generalized to the wider
population. In experimental research designs, selection bias can be reduced through
the random selection and assignment of participants (Etikan, 2017). Random assignment
ensures that the participants are randomly allocated to a group and are comparable across
a range of general and specific characteristics including age and gender (Etikan, 2017).
Selection bias is more likely to occur in research designs that do not randomly select or
assign participants such as in quasi-experimental research like observational cohort
studies or when purposive sampling is used, and this is a threat to the external validity of
these types of studies (Pearce & Richiardi, 2014). Despite adequate selection techniques,
the generalizability of the study results may be affected by extraneous variables that
relate to the characteristics of the sample such as attitude, personality, culture over which
the researcher has no control and these act as confounders (Kamangar, 2012; Sullivan,
2016). The uptake of cervical cancer screening is not only dependent on institutional
factors but also on the attitude, knowledge and perceptions of the women who are eligible
for cervical cancer screening (Dulla et al., 2017; Ndejjo et al., 2016). This quantitative
study did not investigate these variables and therefore these will affect how the results are
interpreted.
Generalization and constructs. The operationalization of the study (how the
constructs, variables and interventions are defined) will affect whether the results from
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the study can be generalized to a wider population. In quantitative research designs,
broad concepts should be narrowed into constructs that can be measured. Constructs are
the building blocks of theories, that help to explain how and why certain phenomena
behave the way that they do. In assessing the determinants of cervical cancer screening
among HIV infected young women, the theory that was utilized was a systems theory and
one of the constructs was service availability that had many parameters. However, in this
study, to measure the construct of service availability, presence of advertised services,
presence of infrastructure, and presence of results delivery systems were some of the
variables that were used to quantify the service availability; the use of multiple variables
to measure a single construct reduces the risk of mono-operation bias, a threat to
construct validity and therefore external validity. Because this was a limited view of
service availability, I could only generalize across the construct and generalizations
across the selected variables to measure service availability within the boundaries of the
operational definition that I provided for the construct of service availability and the
measurement variables.
Internal Validity
Confounding and extraneous variables. Confounding variables or confounders
are those variables that can provide an alternative explanation for the results if they are
present and are inherent characteristics in a study subject that the researcher cannot
modify or remove, these include, age, sex, socioeconomic status, religion, education level
(Kamangar, 2012). If these variables are not being studied, then they are also known as
extraneous variables (Kamangar, 2012). Both confounding and extraneous variables can
threaten the internal validity of the results. In experimental research design, these
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extraneous variables can be controlled for by for instance case controlling and therefore
reduce the confounding effect ( Sullivan, 2016). In my study that was not case controlled,
the potential for confounding and extraneous variables was high and a consideration of
testing of influence on the dependent variable by specific confounding variables such as
location of the clinic and the ownership of the clinic was made.
Ethical Procedures
In secondary data analysis, the original data were not collected to answer the
present research question. My research used secondary data that were routinely collected
at facilities and aggregated at the Ministry of Health HMIS Unit. I used data collected by
the HMIS until March 2018 and provided a list of variables to inform the dataset
requested from the SIU. I sought permission from the Ministry of Health to obtain
deidentified facility level data. De-identified or anonymized information promotes
privacy and prevents breach of patient confidentiality policies (Fullerton & Lee, 2011).
Only data that pertained to HIV infected AGYW from the HIV care facilities were
requested to prevent unnecessary data collection (Brakewood & Poldrack, 2013). The
SIU de-identified all data that was shared and because I used a specific population within
each facility population, all attempts were made to ensure that individual patients could
not be identified by removing all patient identifying numbers and addresses. Because
there were no direct interactions with the target population, no consent was sought from
them (Wilkinson et al., 2016). Some of the data such as SARA requires no prior
permission and is available on the government website and therefore consent to use it was
implied. However, the HMIS unit provided me with a complete dataset including all the
data extracted from the SARA. All the data was obtained electronically and was stored on
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password protected external hard drives. The files were encrypted to prevent accidental
exposure of the data. There were no hard copies of the data and therefore there was no
need for a locked cabinet designated for data storage. Only the statistician and I had
access to the data. All data will be kept in accordance with the Walden Institutional
Review Board (IRB) which is five years. In addition to the University’s IRB (number 0806-18-0665327), I obtained permission from the Ministry of Health Research Review
Board (number SRH027/2018) to publish and disseminate the results of the research.
Summary
My research set out to investigate the institutional factors that affected the uptake
of cervical screening among HIV-positive young women who were disaggregated into
adolescent girls aged 15 – 18 years and young women aged 19 – 24 years. The factors
that were investigated were: the availability of cervical cancer screening services, the
presence of trained health care providers, provision of referral for services and
differences in uptake of screening by age. This was a quantitative cross-sectional
descriptive research design using secondary data. The secondary data included routinely
collected patient level data and survey data, all of which were housed at the Swaziland
Ministry of Health Strategic Information Unit. Bi-variate analysis was used to examine
the relationships between the institutional factors and the uptake of cervical screening.
Logistic regression was used to determine the influence of one or multiple variables on
each other and the dependent variable. All data were described using frequency tables or
histograms as appropriate. The potential limitations of this research included: the use of
secondary data and therefore not all parameters of cervical cancer screening were
interrogated and not all confounding variables could be controlled for thereby impacting
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on internal validity; it was a cross-sectional study and therefore causation could not be
determined; no patient perspective was collected and analyzed and this limited the depth
of the research, and this study was only conducted among HIV-positive young women
whose demographics may be different from HIV-negative young women thus limiting the
generalizability of the results. Ethical considerations in this study included the use of deidentified data, all data were encrypted and only shared with the statistician who assisted
with the statistical analysis. Approvals for data use and dissemination of results were
sought from both Swaziland Ministry of Health Strategic Information Unit and the
Walden University IRB and obtained prior to the start of the study.
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Section 3: Presentation of Results and Findings
Introduction
In this quantitative retrospective study using secondary data, I sought to test the
relationships between health system factors that predict the uptake of cervical cancer
screening among HIV-infected AGYW aged 15 to 24 in Swaziland.
Data Collection
Secondary data from the 2017 Swaziland SARA that included HIV care and
treatment and cervical cancer services variables and routinely collected data in the HMIS
were used in this study. The SARA survey is a comprehensive health facility-based
assessment tool used to appraise the availability of health services based on a standard set
of indicators and health facility readiness to implement services (WHO, 2016). The
SARA survey data were collected between May and October 2017. Following conditional
Walden University IRB approval (number 08-06-18-0665327) on August 6, 2018, I
submitted a data request to the Swaziland HMIS to provide the two datasets: SARA and
routinely collected patient information. I received approval from the HIMS on September
9, 2018 (SRH027/2018) and on September 12, 2018, received full approval from the
Walden IRB to conduct my study. The HMIS provided deidentified data based on the
data request form in two datasets—facility and training information in one dataset and
patient level information in the other dataset. The HMIS did not have available data on
referrals for cervical cancer screening for eligible AGYW and instead provided data on
referrals for AGYW who had a positive visual inspection with acetic acid screen.
Additionally, there were no data available on the outcomes of the referrals. The study
population was HIV-positive AGYW 15 to 24 enrolled in HIV care and treatment. All
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AGYW in the HIV care facilities that provided cervical cancer screening were included
in the dataset and therefore the sample was considered representative of the population.
IBM SPSS version 25 was used for data analysis. Descriptive analysis included
frequencies for categorical data and mean and median for continuous data. Correlation
analysis was used to analyze relationships between variables and included Chi-Square,
the Cochran Armitage test of trend, and the test of two proportions. Binomial logistic
regression analysis was used to test the predictive model of all significant variables. The
level of statistical significance accepted for all tests was p = .05. The dependent variable
for this study was uptake of cervical cancer screening. The specific health systems factors
evaluated included presence of trained health care providers, presence of cervical cancer
screening infrastructure, provision of referrals as well as differences in uptake between
age groups. These were the predictor variables in the study.
Descriptive Statistics
Health Facilities
There are 330 health facilities across the four regions in Swaziland. One hundred
and eighty-five (56.1%) offer HIV care and/or HIV treatment services. Of these 185
facilities, 110 (59.46%) offer cervical cancer screening. Apart from the Shiselweni region
(20, 18.2%), Hhohho (29, 26.4%), Manzini (32, 29.1%), and Lubombo (29, 26.4%) had
similar numbers of facilities providing cervical cancer screening. Most of the facilities
(66, 60%) were in rural areas. The distribution of facilities offering cervical cancer
screening are in Figure 2.
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Figure 2. Distribution of types of facilities offering cervical cancer screening services.
The health facilities in Swaziland are classified as either government,
mission/nongovernment organizations, industries, or privately owned. Government owns
the most facilities (60, 54.5%) followed by mission/nongovernment organizations (25,
22.7%), private (21, 19.1%) and then industries (4, 3.6%). Table 3 provides a summary of
the distribution of facilities by location, ownership, and type.
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Table 3

Distribution of Facilities that Offer Cervical Cancer Screening by Type, Ownership, and
Location
Facility ownership
Government

Mission/NGO

Industry

Private

Total

Rural
Hospital

1

1

0

0

2

Health center

4

0

0

0

4

Public health unit

2

1

0

0

3

Clinic with maternity

5

3

0

0

8

Clinic without maternity

34

12

1

2

49

Urban
Hospital

4

1

1

3

9

Health center

1

0

0

0

1

Public health unit

5

0

0

0

5

Clinic without maternity

4

7

2

16

29

Note. NGO = nongovernment organization
Adolescent Girls and Young Women
There were 12,329 AGYW enrolled in 118 (69.2%) of the 185 HIV care facilities
by the end of March 2018. Based on the eligibility criteria, 1,711 AGYW were in care for
less than 1 year and were excluded from the study. A total of 10,618 AGYW were
included in the study: 9,956 AGYW were in 81 facilities that provide cervical cancer
screening, and 662 AGYW were in 37 facilities that do not provide cervical cancer
screening. Figure 3 shows the patient flow during the study.
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Figure 3. Study participant flow.
The mean age of the 10,618 AGYW was 20.96 (SD 2.734). Two thousand one
hundred and nineteen AGYW (2,119, 20%) were between the ages of 15 to 18 years and
their mean age was 16.62, whereas 8,499 AGYW (80%) were between the ages of 19 to
24 and their mean age was 22.1. Of the 10,618 AGYW, 575 (5.9%) were not on
antiretroviral therapy and 10,043 (94.1%) were on antiretroviral therapy. Of those on
antiretroviral therapy, the mean length of time on treatment was 3.83 years (SD 3.37)
with a minimum of 1 year and a maximum of 17 years. The group of AGYW who were
not on treatment were not assessed for length of time in care as the current data systems
do not capture date of enrollment into care.
The majority of AGYW are found in the hospitals (5,749, 54.14%) followed by
the clinics without maternity (2,467, 23.23%). The least numbers of AGYW were found
in the clinics with maternity (262, 2.47%) and the public health units (526, 4.95%). This
distribution pattern did not differ by age group. However, in the pre-antiretroviral therapy
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group, there were no AGYW enrolled in care in either the public health units or in clinics
with maternity services. See Table 4.
Table 4
Distribution of Adolescent Girls and Young Women in Facilities by Age and Treatment
Status
Facility type
Hospital

Health
center

Clinic with
maternity

Clinic
without
maternity

26

61

421

500

201

1981

0

0

6

0

0

59

Public
health unit

Total

On ART
15 - 18

1,177

443

19 - 24

4,126

1107

2,128
7,924

Pre-ART
15 - 18

76

9

19 - 24

370

55

91
484

Note. ART = antiretroviral therapy
Urban facilities had more AGYW enrolled in HIV care than did rural facilities: 5,670
(53.39%) compared to 4,948 (46.61%). Table 5 summarizes the distribution of the
AGYW by age group and facility location.
Table 5
Distribution of Adolescent Girls and Young Women by Age and Facility Location

Age group

15 - 18
19 - 24

Rural
1,131
3,817

Location
Urban
1,088
4,582

Total
2,219
8,399
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Statistical Analysis
Cochran-Armitage test of trend, Chi-Square test, test of two proportions, and
binomial logistic regression were used as the inferential analysis to test the relationships
between the dependent and the independent variables.
Association Between Trained Health Care Providers and Cervical Cancer Screening
Trained health care providers are one of the determinants for cervical cancer
screening (Choma & Mckeever, 2015; Rosser, Hamisi, Njoroge, & Huchko, 2015).
Multiple SARAs that have been conducted for cervical cancer show that the availability
of trained health care providers improve the uptake of cervical cancer screening among
women attending health care facilities (O’Neill, Takane, Sheffel, Abou-Zahr, & Boerma,
2013; WHO, 2016). I sought to determine whether there was a linear association between
the number of trained staff available and the number of AGYW who received cervical
cancer screening. The research question and hypotheses were:
Research Question 1: What is the relationship between the availability of trained
health providers and the uptake of cervical cancer screening among HIV-positive
adolescent girls and young women in Swaziland?
H01: There is no relationship between the availability of trained health care
providers and the rate of uptake of cervical cancer screening among HIV-positive
adolescent girls and young women.
Ha1: There is a relationship between the availability of trained health care
providers and the uptake of cervical cancer screening among HIV-positive adolescent
girls and young women.

77
The mean number of staff available for cervical cancer screening per facility was
3.19 (SD 4.21, 0-22). Most of the facilities (70, 63.6%) had one to two staff available to
conduct cervical cancer screening, whereas five facilities that offer cervical cancer
screening had no staff available. The hospitals reported the highest number of staff (11+
staff) available for cervical cancer screening followed by the public health units (six to 10
staff). See Table 6.
Table 6
Number of Trained Staff to Conduct Cervical Cancer Screening by Facility Type

Hospital
Health center
Public health unit
Clinic with maternity
Clinic without maternity
Total

0
0
0
0
0
5
5

Staff available
1-2
3-5
6 - 10
2
2
1
1
3
1
2
1
5
8
0
0
57
12
4
70
18
11

11+
6
0
0
0
0
6

Total
11
5
8
8
78
110

The majority of the facilities (97, 88.2%) offering cervical cancer screening had
staff who have been trained on cervical cancer screening in the last 2 years; 57 (58.8%),
are in rural localities, and 40 (41.2%) are in urban localities. All hospitals (11) and health
centers (five) had staff who have been trained in last 2 years, whereas 87.5% of the staff
in public health units (seven out of eight) and clinics with maternity (seven out of eight)
and 85.9% of staff in clinics without maternity (67 out of 78) had received training in the
last 2 years.
The Cochran-Armitage test of trend was used to determine whether there was a
linear association between number of trained staff and uptake of cervical cancer
screening because the number of trained staff was an ordinal independent variable and
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the uptake of cervical cancer screening was a dichotomous dependent variable (see
Bianchi et al., 2012; Wellek & Ziegler, 2012). The grouping of trained staff was
considered ordinal as the grouping was zero staff, one to two staff, three to five staff, six
to 10 staff and 11 or more staff. The assumptions to conduct the Cochran-Armitage test
of trend included the presence of an ordinal independent variable, the dependent variable
must be dichotomous, and that there ia a linear relationship/association between the two
variables but not whether the trend is linear. The limitation of this test is that it does not
test for curvilinear components. These assumptions were met by the study.
The proportion of AGYW who received cervical cancer screening was per
grouping of staff available in the facilities were one to two staff (0.176), three to five staff
(0.172), six to 10 staff (0.358), and 11 or more staff (0.216). See Table 7.
Table 7
Adolescent Girls and Young Women Who Received Screening and Number of Trained
Staff Available
Trained staff

Yes

Screened

1-2

3-5

6 - 10

11+

N

353

548

373

803

17.60%

17.20%

35.80%

21.60%

1655

2540

669

2915

82.40%

82.80%

64.20%

78.40%

2008

3188

1042

3718

20.17%

32%

10.47%

37.34%

% AGYW screened
within Trained staff
N

No

% AGYW not
screened within
Trained staff
Total
% AGYW per
trained staff
grouping
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The Cochran-Armitage test of trend showed a statistically significant linear trend
between number of trained staff and the uptake of cervical cancer screening score =
30.307, df (1), p = .000. The Cochran-Armitage test of trend was statistically significant
(p < .05). Therefore, the null hypothesis was rejected in favor of the alternative
hypothesis.
Availability of Cervical Cancer Screening Services
The WHO has defined a set of characteristics that determine the availability of
cancer screening services in health facilities (WHO, 2013a). In Swaziland, the service
characteristics criteria are based on the ability to conduct visual inspection with acetic
acid for eligible women younger than 40 years and ability to conduct a PAP smear in
women older than 40 years (Kessler, 2017; WHO, 2013b). The characteristics for visual
inspection with acetic acid provision are presence of speculums, acetic acid, laboratory
whether onsite or offsite, system for results retrieval and delivery to client, availability of
guidelines, information and educational material, and advertisement of facilities (WHO,
2013a). These characteristics were assessed during the SARA survey conducted in 2017.
The research question and hypotheses were:
Research Question 2: What is the relationship between the availability of cervical
cancer screening services in a facility and the uptake of cervical cancer screening among
HIV-positive adolescent girls and young women in Swaziland?
H02: There is no relationship between the availability of cancer screening services
within a facility and the uptake of cervical cancer screening.
Ha2: There is a relationship between the availability of cervical cancer screening
services within a facility and the uptake of cervical cancer screening.
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There were 10,618 AGYW eligible for cervical cancer screening: 9,956 (93.8%)
AGYW were in 81 facilities that provided cervical cancer screening and 662 (6.2%)
AGYW were in 37 facilities that did not provide cervical cancer screening. A total of
2171 (20.45%) AGYW were screened: 2,077 (95.67%) AGYW were in facilities that
provided cervical cancer screening and 94 (4.33%) AGYW were in facilities that did not
provide cervical cancer screening. See Table 8.
Table 8
Availability of Screening Services and Cervical Cancer Screening Uptake
Screened
Facility has cervical cancer screening services
Yes

N
% within Cervical cancer screening services

Yes
2077
20.9%

No
7879
79.1%

Total
9956
100.0%

No

N
% within Cervical cancer screening services

94
14.2%

568
85.8%

662
100.0%

Total

N
% of Total

2171
20.4%

8447
79.6%

10618
100.0%

A Chi square test of association was carried out to test for the relationship
between two nominal/dichotomous variables: availability of cervical cancer screening
services and uptake of cervical cancer screening (Schumacker & Tomek, 2013). My data
met the three assumptions required to conduct a Chi square test of association: there are
two variables, both of which were categorical, there was independence of observations
and all cells met the expected counts of more than five (Lund Research Ltd, 2013). The
Chi square only informs whether the null hypothesis of no association can be rejected and
not the magnitude of any association. To assess the magnitude of any association
detected, Phi (φ) was used (Harmatz & Greenblatt, 2015; Janzing, Balduzzi, Grosse-
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Wentrup, & Schölkopf, 2013). Phi (φ) is a measure of the strength of association of a
nominal by nominal relationship when the variables are dichotomous. Its range is from
negative one to positive one (-1 to +1).
There was a statistically significant association between availability of cervical
cancer screening services and uptake of cervical cancer screening, χ2(1) = 16.939, p =
0.00. There was a positive but weak association between availability of cervical cancer
screening services and uptake of cervical cancer screening, φ = 0.04, p = 0.00. Therefore,
we can reject the null hypothesis in favor of the alternative hypothesis.
Additional analysis of facilities that provide cervical cancer screening. Of the
110 facilities offering cervical cancer screening, 89.1% had speculums available, 66.4%
had acetic acid, 1.8% had a laboratory onsite to examine samples, 64.5% had guidelines
available, 52.7% had informational and educational material available and 32.7%
advertised cervical cancer screening.
A binomial logistic regression was conducted to determine whether any of these
characteristics could predict uptake of cervical cancer screening. A binomial logistic
regression is used to determine whether or not there is a relationship between a
dichotomous dependent variable and two or more independent variables that may be
categorical or continuous at the same time assessing for the potential influence of other
explanatory variables on that relationship (Laerd Statistics, 2013; Sperandei, 2014).
Therefore, binomial logistic regression can be used for a) controlling for other
explanatory variables when assessing relationships between a dependent dichotomous
variable and multiple independent variables b) predicting the probability of an event
happening for an individual (Laerd Statistics, 2013). The main advantage of conducting a

82
binomial logistic regression is to avoid confounding effects by analyzing the association
of all variables together. Several assumptions must be met to conduct the binomial
logistic regression: there is one dependent variable that is dichotomous, there are one or
more independent variables that are measured either on a continuous or nominal scale,
there is independence of observations and the categories of the dependent and
independent variables are mutually exclusive, the minimum number of cases per variable
is 15, there should be a linear relationship between the continuous independent variables
and the logit transformation of the dependent variable; there should be no
multicollinearity; and there should be no significant outliers (Sperandei, 2014). My data
set fulfilled all the assumptions.
A binomial logistic regression was performed to ascertain the effects of the
presence of equipment, diagnostics, laboratory, results return mechanism, guidelines,
information and educational material and advertisement of services at the facilities on the
likelihood that participants would undergo cervical cancer screening. In this model there
were no continuous variables and no outliers. The logistic regression model was not
statistically significant, χ2(7) = 8.761, p =.270. The Hosmer and Lemeshow test that tests
for goodness of fit in a regression model was not statistically significant (p = .764),
indicating that the model is not a poor fit. The Hosmer and Lemeshow test is a
formal test of the null hypothesis that the fitted model is correct, and its output is a pvalue- a number between 0 and 1 with higher values indicating a better fit. The model
explained only 0.10% (Nagelkerke R2) of the variance in cervical cancer screening and
correctly classified 82.1% of the cases. None of the seven predictor variables were
statistically significant as shown in Table 9.
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Table 9
Likelihood for Screening Based on Availability of Cervical Cancer Screening
Infrastructure

B

S.E.

Wald

df

p

Odds
Ratio

95% C.I. for Odds
Ratio
Lower

Upper

Availability of speculums

.106

.162

.428

1

.513

1.111

.810

1.526

Availability of acetic acid

-.067

.107

.386

1

.534

.935

.758

1.154

Laboratory to examine
samples

-.048

.107

.198

1

.656

.954

.773

1.176

Presence of a mechanism
to return results to clients

-.244

.166 2.150

1

.143

.784

.566

1.085

Facility has Cervical
cancer screening
guidelines

-.051

.118

.187

1

.665

.950

.754

1.198

Facility has in-service
communication materials
on cervical cancer

.059

.090

.438

1

.508

1.061

.890

1.265

Advertisement of cervical
cancer screening services

-.150

.084 3.221

1

.073

.860

.730

1.014

-1.026

.367 7.815

1

.005

.358

Constant

Association Between the Frequency of Services Offered and Uptake of Cervical
Cancer Screening
Service availability affects accessibility to the services. Service availability is
characterized by the type of service delivery (fixed, mobile, outreach), frequency of
service delivery (daily, weekly, monthly) and times of service delivery (8:00 – 5:00, 24
hours; WHO, 2015).
Almost 96% (105, 95.5%) of facilities reported offering cervical cancer screening
on a daily basis, 3.6% (four) of facilities reported offering services twice a week and only
0.9% (one) reported offering services thrice a week. A Chi square test of association was
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carried out to test for the association between two nominal/dichotomous variables:
frequency of services offered and uptake of cervical cancer screening (Schumacker &
Tomek, 2013). My data met the three assumptions required to conduct a Chi square test
of association: there are two variables, all of which were categorical, there was
independence of observations and all cells met the expected counts of more than five
(Lund Research Ltd, 2013). The Chi square only informs whether the null hypothesis of
no association can be rejected and not the magnitude of any association. To assess the
magnitude of any association detected, Phi (φ) was used (Harmatz & Greenblatt, 2015;
Janzing et al., 2013). Phi (φ) is a measure of the strength of association of a nominal by
nominal relationship when the variables are dichotomous. Its range is from -1 to +1. A
chi-square test for association was conducted between frequency of services offered and
uptake of cervical cancer screening. All expected cell frequencies were greater than five.
There was no statistically significant association between frequency of services offered
and uptake of cervical cancer screening, χ2(2) = 0.568, p = 0.753. There was a very weak
association between frequency of services offered and uptake of cervical cancer
screening, φ = 0.008, p = 0.753 and therefore we cannot reject the null hypothesis in
favor of the alternate hypothesis.

85

Figure 4. Uptake of cervical cancer screening by frequency of screening services.
Proportion of screened adolescent girls and young women who receive their
results within one month. On average, 40.74% (SD +/- 12.88%, range: 62%) of AGYW
who have received cervical cancer screening and require further laboratory testing will
receive their results within four weeks. Those in the urban areas are more likely to
receive their results within four weeks than those in the rural areas, 46% vs 31.59%.
There was no difference in proportion of clients who received results between facilities
whose staff had been trained in the last two years and those who had not been trained:
37.32% versus 37.77%.
Core Characteristics for Cervical Cancer Screening and its Uptake
Twenty-three (20.9%) facilities had all the core service characteristics that
classify the facility to have cervical cancer services, 87 facilities had some of the
characteristics and 75 facilities did not have any cervical cancer screening services. Of
the 23 facilities with all the core service characteristics, six (26.1%) are hospitals, eleven
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(47.8%) are clinics without maternity, two (8.7%) are public health units, two (8.7%) are
clinics with maternity and one (4.34%) is a health center. See Table 10.
Table 10
Summary of Facilities and Core Service Characteristics for Cervical Cancer Screening
Facility offers cervical
screening
No, Does not have any
core service characteristics

Yes, has some core service
characteristics

Yes, has all the core
service characteristics

Facility Type
Clinic with Maternity

Frequency (N)
4

Percent
5%

Clinic without
Maternity
Hospital
Clinic with Maternity

69

92%

2
6

3%
7%

Clinic without
Maternity
Health Center
Hospital
Public Health Unit
Clinic with Maternity

67

77%

3
5
6
2

3%
6%
7%
9%

Clinic without
Maternity
Health Center

11

48%

2

9%

Hospital
Public Health Unit

6
2

26%
9%

Within the 23 facilities with all the core service characteristics, there were 6,434
AGYW of whom 1197 received cervical cancer screening. In the 87 facilities that had
some of the core service characteristics, there were 3,522 AGYW of whom 880 received
cervical cancer screening and in the 75 facilities without any core service characteristic,
there were 662 AGYW of whom 94 received cervical cancer screening. See Table 11.
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Table 11
Uptake of Cervical Cancer Screening by Availability of Core Service Characteristics

All core service characteristics

Some core service
characteristics
No core service characteristics

Total

N
% within screening
uptake
N
% within screening
uptake
N
% within screening
uptake
N
% within screening
uptake

Screening uptake
Total
Yes
No
1197
5237
6434
55.1%
62.0%
60.6%
880
40.5%

2642
31.3%

3522
33.2%

94
4.3%

568
6.7%

662
6.2%

2171
100.0%

8447
100.0%

10618
100.0%

A Cochran-Armitage test of trend was run to determine whether a linear trend
exists between the availability of core service characteristics and the proportion of
AGYW who received cervical cancer screening. The availability of core service
characteristics was classified as having all core service characteristics (n = 6434), having
some core service characteristics (n = 3522) and having no core service characteristics
(n = 662), and the proportion of AGYW who received a cervical cancer screening was
0.551, 0.405 and 0.043, respectively. The Cochran-Armitage test of trend showed a
statistically significant linear trend, p = .002, with facilities having all core service
characteristics associated with a higher proportion of AGYW who received a cervical
cancer screening.
The association between referrals and the uptake of cervical cancer
screening. The uptake of health services can be enhanced by the provision of referrals to
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clients actively by health care providers (Denno, Hoopes, & Chandra-Mouli, 2015). This
is especially noted when those services are not available in the local health facility
(Shannon, Vinson, Cook, & Lennon, 2016). The research question and hypothesis were:
Research Question 3: What is the relationship between the provision of a referral
for cervical cancer screening among eligible women and the uptake of cervical cancer
screening among HIV-positive adolescent girls and young women in Swaziland?
H03: There is no relationship between the provision of a referral for cervical
cancer screening in eligible women and the uptake of cervical cancer screening.
Ha3: There is a relationship between the provision of a referral for cervical cancer
screening in eligible women and the uptake of cervical cancer screening.
The data provided by HMIS did not have data on referrals for screening but rather
referrals for further management of a positive visual inspection with acetic acid test. The
data were also missing the outcomes of the referrals. The analysis, therefore tested for an
association between the age of the AGYW and the provision of a referral for further
management. HIV adolescent girls and young women who have a positive screen need to
receive further testing and treatment as a matter of urgency as they are more likely to
develop cervical lesions that may rapidly progress to neoplasia (Peto, 2014; Salakos,
Paltoglou, & Top, 2014; Singh, Chilton, & Prime, 2012). However, more young women
than adolescent girls are more likely to be referred for further testing and treatment
because of provider bias, accessibility to services and demand side barriers (Bardají et al.,
2018; Finocchario-Kessler et al., 2016; Ghebre, Grover, Xu, Chuang, & Simonds, 2017;
Kasting et al., 2016).
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Of the 220 AGYW whose cervical cancer screening test was positive (49 were in
age group 15 – 18 and 171 were in 19 - 24 age group), only 56 (25.5%) were provided
with a referral for further evaluation. Twelve (21.43%) were in the age group 15 – 18
years and 44 (78.57%) were in the age group 19 – 24 years. By age group, there was little
difference between the proportion of those who were15 -18 years old and 19 -24 years
old who received referrals: 24.5 % compared to 25.7% respectively. Hospitals provided
most of the referrals (46.43%) followed by clinics without maternity (33.93%). Table 12
summarizes the distribution of the AGYW who received a referral by age group, and
Table 13 summarizes the distribution of the AGYW who received a referral by facility
type.

Table 122
Referrals to Adolescent Girls and Young Women with Positive Cervical Cancer
Screening by Age
Provision of referrals
Age Group
N
15 - 18 years

% within Provision
of referrals

Yes

No

Total

12

37

49

21.40%

22.60%

22.30%

90
% of Total

19 - 24 years

N
% within Provision
of referrals
% of Total
N

All AGYW

% of Total

5.50%

16.80%

22.30%

44

127

171

78.60%

77.40%

77.70%

20.00%

57.70%

77.70%

56

164

220

25.50%

74.50%

100.00%

Table 13
Referrals to Adolescent Girls and Young Women by Age Group and Facility Type
Facility Type
Public
Clinic
Clinic
Health
Health
with
without Total
Center
Unit Maternity Maternity

Age
Group

Provision of
referral

Hospital

15 to 18
years

Yes
No

5
20

3
8

0
1

1
2

3
6

12
37

19 to 24
years

Yes
No

21
64

6
21

0
9

1
2

16
31

44
127

Total

Yes
No
Total

26
84
109

9
29
38

0
10
10

2
4
6

19
37
57

56
164
220

A chi-square test for association was conducted to test the association between
age group of the AGYW and the provision of a referral. All expected cell frequencies
were greater than five. There was no statistically significant association between age
group of the AGYW and provision of a referral, χ2(1) = 0.031, p = 0.860. The association
between age group and provision of a referral was weak as well, φ = -0.012, p = 0.860.
Therefore, we cannot reject the null hypothesis in favor of the alternative hypothesis.
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Difference in Uptake of Cervical Cancer Screening by Age
Age is a determinant of cervical cancer screening both from a systems perspective
and an individual perspective (Massad et al., 2013; Morema, Atieli, Onyango, Omondi, &
Ouma, 2014; Salvatore Vaccarella, Lortet-Tieulent, Plummer, Franceschi, & Bray, 2013).
Teenagers are less likely to access sexual and reproductive health services due to fear of
discrimination and prejudice by the health facility staff and a fear of being rebuked by
their parents whereas young women tend to be marginalized due to socioeconomic and
cultural influences (Chapman Lambert, 2013; Morema et al., 2014; Waller, Jackowska,
Marlow, & Wardle, 2012). HIV infected AGYW enrolled in care present a unique
opportunity to offer cervical cancer screening routinely for eligible AGYW (Morema et
al., 2014; Waller et al., 2012). Based on the recent Cervical Cancer Screening guidelines,
all HIV infected girls and women (if infection was not obtained perinatally) should be
screened at diagnosis of HIV and thereafter annually regardless of their treatment status
(Isidean, Louvanto, & Franco, 2014; WHO, 2013b). In this study, I sought to determine
whether there was a difference in uptake of cervical cancer screening between adolescent
girls and young women. The research question and hypotheses were:
Research Question 4: Is there a difference in uptake of cervical cancer screening
between HIV-positive adolescent girls and HIV-positive young women?
H04: There is no difference in uptake of cervical cancer screening between HIVpositive adolescent girls and HIV-positive young women.
Ha4: There is a difference in uptake of cervical cancer screening between HIVpositive adolescent girls and HIV-positive young women.
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Of the 10,618 AGYW who were eligible for cervical cancer screening, 2219 were
in the age group 15 - 18 years and 8399 were in the 19 -24-year age group. Only 2171
(20.44%) had received cervical cancer screening in the last 12 months. Of the 2171
AGYW who were screened, 471 were in the age group 15 to 18 years and on
antiretroviral therapy, 1610 were in the age group 19 to 24 years and on antiretroviral
therapy while 10 in the age group 15 to 18 years and 90 in the age group 19 to 24 years
were in pre-antiretroviral therapy care. Figure 5 illustrates the distribution of the AGYW
by age group and treatment status while Table 12 provides a summary of the
crosstabulation between Age group of the AGYW by cervical cancer screening status.

Figure 5. Distribution of adolescent girls and young women by age group and treatment
status.
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Table 14
Age Group by Screening Status
Screening
Age Group
15-18
19-24

Total

N
% within Age Group
N
% within Age Group
N
% of Total

Total

Yes

No

481
21.7%
1690

1,738
78.3%
6709

2,219
100.0%
8399

20.1%

79.9%

100.0%

2171

8447

10618

20.4%

79.6%

100.0%

The test of two proportions also known as the Chi-square test for homogeneity
was used to determine the difference in uptake of cervical cancer screening between
adolescent girls and young women. The test of two proportions can be used to assess if a
difference exists between the proportions of two independent groups on a dichotomous
dependent variable. Four assumptions need to be met to use this statistical test: both
independent and dependent variables are dichotomous, the observations are independent
of each other, the sample size should be more than 5 observations and retrospective
purposively sampled two groups each having a specific characteristic. My dataset met all
these assumptions and the test of two proportions was conducted. Ten thousand, six
hundred and eighteen (10,618) AGYW were grouped according to whether they were
adolescent girls (15 – 18 years) or young women (19 -24 years), 2,219 in the 15 – 18 year
age group and 8,399 in the 19 – 24 year age group. Four hundred and eighty one in the
15 – 18 year age group (21.67%) received cervical cancer screening compared to 1,690
(20.12%) in the 19 – 24 year age group, a non-statistically significant difference in
proportions of 1.56, p= 0.106. The difference between the two independent binomial
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proportions was not statistically significant (p > .05). Therefore, we fail to reject the null
hypothesis and cannot accept the alternative hypothesis.
Summary of Results
Using secondary data that had been de-identified and provided by the HMIS unit
at the Ministry of Health in Swaziland (formerly Swaziland), I studied the determinants
of cervical cancer screening among HIV positive AG and YW enrolled in HIV care and
treatment using three of the original four research questions:
Research Question 1: What is the relationship between the availability of trained
health providers and the uptake of cervical cancer screening among HIV-positive
adolescent girls and young women in Swaziland?
Research Question 2: What is the relationship between the availability of cervical
cancer screening services in a facility and the uptake of cervical cancer screening among
HIV-positive adolescent girls and young women in Swaziland?
Research Question 4: Is there a difference in uptake of cervical cancer screening
between HIV-positive adolescent girls and HIV-positive young women?
For RQ 3 that was examining the relationship between the provision of a referral
for screening and the uptake of cervical cancer screening among HIV-positive AGYW in
Swaziland, the data provided by HMIS consisted of referrals provided to HIV-positive
AGYW who had received a cervical cancer screening and the screen was positive.
Therefore, I analyzed the relationship between the provision of referral for further
management and age group of the HIV-positive AGYW.
Most facilities (70%) had 1-2 trained staff available for cervical cancer screening
but the most screening (35%) occurred in facilities where there were 6-10 trained staff
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available for cervical cancer screening. A Cochran- Armitage test of trend was conducted
to determine the presence of any linear association between number of trained staff and
the uptake cervical cancer screening by age group. There was a statistically significant
difference in the uptake of cervical cancer screening based on number of trained staff
available (p= 0.00) and therefore I rejected the null hypothesis in favor of the alternate
hypothesis.
To determine the uptake of cervical cancer screening based on availability of
cervical cancer screening services, I compared the AGYW who received screening in
facilities with cervical cancer screening services and those who received screening in
facilities without the cervical cancer screening services. There was a statistically
significant but weak association between availability of cervical cancer screening
services and uptake of cervical cancer screening (χ2(1) = 16.939, p = 0.00, φ = 0.008),
therefore I rejected the null hypothesis in favor of the alternate hypothesis. Using the
Cochran-Armitage test of trend, I also assessed the uptake of cervical cancer screening in
those facilities that had all the characteristics, those that had some of the characteristics,
and those that had none. AGYW who were in facilities that had all the component
infrastructure were more likely to receive cervical cancer screening than those in facilities
who did not have all the components (p = 0.002) and therefore I rejected the null
hypothesis in favor of the alternate hypothesis
I used a Chi square test of association and Phi φ to describe the association
between frequency of service availability and uptake of cervical cancer screening. There
was no statistically significant association between the frequency of services offered and
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the uptake of cervical cancer screening (p=0.753) and therefore I accepted the null
hypothesis.
The test of two proportions was conducted to determine if there was any
difference in uptake of cervical cancer screening in the adolescent girls compared to
uptake among the young women. The proportions by age group of AGYW who received
cervical cancer screening were similar: 21.67% among adolescent girls compared to
20.12% among young women, a nonstatistically significant difference in proportions of
1.56, p = 0.106. The difference between the two independent binomial proportions was
not statistically significant (p > .05) and therefore, I failed to reject the null hypothesis.
The data to test the association between cervical cancer screening and referral for
screening were not available and the HMIS instead provided data on referral for further
management for a positive visual inspection with acetic acid screen. This information
was analyzed for which age group was more likely to receive a referral for further
management for a positive visual inspection with acetic acid screen. Although more
young women (44,78.6%) received a referral, the difference in proportions by age group
was small: 24.5% among AG compared to 25.7% among young women and was not
statistically significant (φ = -0.012, p=0.861) and therefore I failed to reject the null
hypothesis. In the next section, I will discuss the interpretations of the results in context
with the literature review, the limitations of the study, recommendations for future
research, implications for social change, as well as an overall conclusion of the study.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
The global burden of cervical cancer, a genital tract cancer caused by infection
with HPV (Bruni et al., 2016), is mainly in the lower- and middle-income countries
where 86% of cases occur (Bruni et al., 2016). Cervical cancer is an AIDS-defining
illness (Chan et al., 2003), and the global distributions of HIV and cervical cancer have
little variation, with the highest rates found in sub-Saharan Africa. In Swaziland, cervical
cancer is the most common cause of cancer-related death among women (Swaziland
Ministry of Health, 2015c).
Women who are infected with HIV are at increased risk of dying from cervical
cancer (Ghebre, Grover, Xu, Chuang, & Simonds, 2017). They are more likely to have
persistent infections with high-risk HPV types and to have rapidly progressive
precancerous lesions (Ginindza, Sartorius, & Za, 2018). Due to this amplified risk,
cervical cancer screening guidelines for HIV-infected and non-HIV-infected women
differ (Kessler, 2017; McGraw & Ferrante, 2014). The screening guidelines for adults
and adolescents also differ. Due to the high rate of spontaneous clearance of HPV
infections and the risks associated with over-screening among adolescents, it is
recommended that screening does not begin until the age of 21 except if an adolescent
girl or young woman is HIV infected (American College of Obstetritians and
Gynecologists, 2016). HIV-infected adolescents are a high-risk population, so cervical
cancer screening is recommended twice in the first year they are diagnosed if they are
sexually active and annually thereafter. However, there are multiple health system factors
that affect cervical cancer prevention: the availability of an organized screening program,
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the existence and quality of the facilities for screening and diagnostic follow-up, and the
facilities available for treating diagnosed lesions (Dollin, 2013; Finocchario-Kessler et
al., 2016). But according to the Swaziland SARA 2017 report, the coverage for cervical
cancer screening in Swaziland is 33% for all women.
The purpose of this study was to examine the relationship between the WHO
recommended service delivery components for cervical cancer screening (WHO, 2014a)
and the uptake of cervical cancer screening among HIV-positive AGYW in Swaziland. I
conducted a retrospective analytical study using secondary data from the SARA survey
conducted in 2017 and routine clinical data that was provided by the Swaziland HMIS
Unit. The data analysis included univariate, bivariate and multivariable analyses that
demonstrated that the presence of trained staff and the presence of all components of a
screening program (equipment, diagnostics, guidelines, in-service communication
materials, laboratory and advertisement of services) had a statistically positive significant
association with the uptake of cervical cancer screening by HIV-positive AGYW. The
findings showed that AGYW enrolled in HIV care with facilities with a larger
complement of staff trained on cervical cancer screening (p = 0.00) and facilities that had
all components required for cervical cancer screening (p = 0.024) were more likely to
receive cervical cancer screening regardless of their age group. There was no difference
in uptake of cervical cancer screening (p = 0.104) or referral for further care (p = 1.0) by
age group.
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Interpretation of the Findings
Study Findings and Past Research
Presence of trained staff to provide cervical cancer screening and uptake of
cervical cancer screening by HIV positive adolescent girls and young women. The
results showed that HIV positive AGYW accessing care in facilities with larger numbers
of staff trained on cervical cancer screening were more likely to receive cervical cancer
screening (p = 0.00). Despite 95% of the facilities having trained staff available to offer
cervical cancer screening, 64% of them had only one to two staff available, and the
number of AGYW who received cervical cancer screening in these facilities was low in
comparison to facilities that had three or more trained staff available. These findings are
similar to other research findings. For example, Rosser et al (2015) reported that a lack of
trained staff affects uptake of cervical cancer screening and recommended education for
both providers and patients to improve uptake. O’Neill et al. (2013) also reviewed
SARAs from six countries, suggesting that workforce availability and competence
affected the provision and uptake of services. Although there may be inadequate
infrastructure, a trained workforce is able to generate and meet demand for the service
thereby increasing uptake and coverage of cervical cancer screening (Coleman et al.,
2016; Kim & Han, 2016). In Swaziland, where the rate of screening for all women is low
at 33%, trained and adequate number of staff can contribute to the uptake and coverage of
cervical cancer screening services. My findings demonstrated that it is not enough to have
trained staff in a facility, but they must also be in adequate numbers (three or more) if the
uptake for cervical cancer screening is to increase
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Availability of cervical cancer screening services. I examined the association
between the availability of cervical cancer screening services at facility level and
AGYW’s uptake of cervical cancer screening. In a bivariate analysis, HIV-positive
AGYW enrolled in care in facilities that had all the recommended components for a
cervical cancer screening service were more likely to receive cervical cancer screening as
compared to facilities with some of the components or those without any of the
components (p = 0.02). Descriptive and logistic regression statistics for each component
of the cervical cancer screening system further illustrated that no single component on its
own had a statistically significant likelihood to improve cervical cancer screening uptake
among the AGYW.
These findings are similar to Parham et al. (2015), who attempted to scale up
cervical cancer screening in a populous town in Zambia using low cost and low
technology methods for screening and treating positive screens during a single visit. But
scaling up cervical cancer screening is not feasible if all components of the screening
service and skilled human resources are not available (Parham et al., 2015). Parham et al.
found that facilities that did not have guidelines or equipment or a laboratory onsite were
less likely to offer the same day service than those that had all components of the
screening service.
Another study related to the current study’s findings was conducted by Maseko et
al. (2015c), who identified barriers to cervical cancer screening in Malawi, a country in
sub-Saharan Africa with one of the highest age-standardized incidence rates of cervical
cancer. Maseko et al. found that there was a lack of policies, lack of trained human
resources and lack of equipment and diagnostics to conduct the screening, that limited
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cervical cancer screening services for eligible women. The barriers to the uptake of
cervical cancer screening can be categorized as individual, community, and health
system. Therefore, to improve the uptake of cervical cancer screening in any country, all
three of these categories need to be addressed simultaneously to generate demand,
address stigma, and improve supply for cervical cancer screening (Maseko et al., 2015b).
I also found that the uptake of cervical cancer screening was higher in the presence of all
components of service delivery (guidelines, equipment, diagnostics, laboratory services
and a results return mechanism, in-service communication and advertisement of the
services) than when some of the components were missing or there was no service at all
that is supported by previous findings and reaffirms the need for the Ministry of Health to
ensure that all service components are available at each level of the health system
(clinics, health centers, and hospitals).
Provision of referrals for further management of a positive screening test.
The timely and appropriate referral for further management of a positive screening test
improves the outcomes of cervical cancer, especially in HIV-infected adolescent girls.
High rates of cervical lesions in adolescent girls are due to high rates of HPV infection
(Foxx et al., 2017; Kerrebroeck & Makar, 2016). However, these lesions clear away
spontaneously in 90% of the population who are not HIV infected (Foxx et al., 2017). In
HIV-infected adolescent girls, many of these lesions do not clear away and rapidly
progress into precancerous and cancerous lesions, making referral for further
management vital for early diagnosis, prevention, and treatment of cervical cancer in this
age group (Ghebre et al., 2017). There was a non-statistically significant difference in
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proportions of adolescent girls who were referred for further care (24.5%) compared to
the proportion of young women who were referred for further care (25.7%), p = 0.860.
These findings are comparable to studies in Malawi, a country with high HIV
prevalence and incidence among AGYW and the highest age standardized incident rates
of cervical cancer in the world. Based on findings from the Malawi Population-Based
HIV Impact Assessment 2015-2016, HIV-infected adolescent girls enrolled in HIV care
were less likely to receive cervical cancer screening and referrals for further management
compared to older age groups (Jonnalagadda et al., 2018), and younger women with
positive cervical cancer screens were less likely to receive follow up for further treatment
(Msyamboza, Phiri, Sichali, Kwenda, & Kachale, 2016a). This is because younger age
groups were less likely to complete follow up or have the resources to go to a treatment
facility and service providers did not prioritize younger age groups for referrals.
Swaziland is similar to Malawi in that HIV-positive adolescent girls with a positive
cervical cancer screen are not referred any differently than HIV-positive young women, a
situation that needs to be addressed. Because of the lack of follow up in this population, it
would be important to either offer same day treatment on site or have a mechanism to
follow up these adolescent girls to ensure that they receive the appropriate treatment.
Difference in cervical cancer screening uptake by age group. Older women are
more likely to receive cervical cancer screening due to less discrimination around
sexuality and generally sexual reproductive health services are more user friendly for
them than for adolescent girls (Boardman & Robison, 2013; Ghebre et al., 2017). I
compared two age-groups: adolescent girls (15–18) and young women (19–24). Findings
of a bivariate analysis showed that there was no statistically significant difference in
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proportions of adolescent girls who received cervical cancer screening (21.7%) and the
proportion of young women who received cervical cancer screening (20%), p = 0.106.
These findings from this study do not align with findings from previous studies.
In South Africa, where HIV and cervical cancer incidence and prevalence is similar to
Swaziland, HIV-infected adolescents were less likely to receive cervical cancer screening
than HIV-infected young women because health care providers are not knowledgeable on
risk of cervical cancer among adolescents and adolescent-friendly health services are not
common despite adolescent girls being a high risk population (Hoque, Ghuman,
Coopoosmay, Van Hal, 2014; Hoque, Ghuman, & Van Hal, 2013; Hoque Monokoane, &
Van Hal, 2014). In addition, in Nigeria, where HPV vaccination is not institutionalized,
routine cervical cancer screening is offered to women above the age of 21 regardless of
their HIV status, and cervical examinations in adolescents are only conducted if there are
specific complaints that skews the uptake of cervical cancer screening in HIV-infected
AGYW to only young women (Ahmed, Ahmed, Idris, & Sabitu, 2013; Awodele et al.,
2011; Ugwu, Obi, Ezechukwu, Okafor, & Ugwu, 2013). In countries where HPV
vaccination is being rolled out or scaled up, it has been demonstrated that adolescent
girls’ knowledge of cervical cancer and their risk for cervical cancer is very low
regardless of their HIV status (Jain, Halder, & Mehrotra, 2016; Kim & Han, 2016;
Leinonen et al., 2017; Subramanian et al., 2016). Implementing strategies to improve
uptake of cervical cancer screening among HIV-infected AGYW equally is a
recommended best practice. Although Swaziland screens them equally, with the current
cervical cancer screening uptake rate among AGYW at only 21.5%, the effort needs to
increase to ensure that all HIV-positive AGYW receive cervical cancer screening
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according to the guidelines. The results from Swaziland may be dissimilar to other areas
because most of the HIV-positive adolescent girls in Swaziland are receiving their care in
hospitals and health centers that run special adolescent clinics and have more trained staff
available to offer the service.
Study Findings and Systems Thinking Theory
This study used the systems thinking theory that posits that multiple elements
with dynamic processes influence a given outcome at varying levels. The systems
thinking theory has been used to improve health outcomes by understanding the
functioning and interactions of elements involved in providing care for patients and the
multiple determinants of health at different levels of the health system (Cordon, 2013).
The more complex the health care required by the patient for example those with HIV
infection, the more likely they are to experience multiple incidences of harm including
the loss of dignity and respect (Classen et al., 2011; Levinson, 2010, 2012). One instance
of harm is the failure to provide patient with relevant care, for instance HIV infected
AGYW who should receive cervical cancer screening but do not (Peters, 2014). I
examined the health system components of trained health providers, service delivery, and
referrals as determinants of the uptake of cervical cancer screening among HIV positive
AGYW. The findings of the study support the systems thinking theory by showing that
HIV positive AGYW enrolled in care in facilities that provide all service delivery
components and had a large enough trained staff complement were more likely to receive
cervical cancer screening than those enrolled in care in facilities that had few or no
trained staff or those enrolled in care in facilities that had some of the service delivery
components or none at all. The systems thinking theory was useful in guiding the
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identification of the study deliverables including the breakdown of the service delivery
elements, the design of the study questions, analysis and the interpretation of the findings.
Limitations of the Study
I used secondary quantitative data that was not purposely collected for this study
and some of the variables were not available for analysis, such as data on the provision of
referrals for cervical cancer screening for AGYW who are in facilities that do not offer
cervical cancer screening in the original context of the study. The service delivery data
were of a cross-sectional nature collected at one point in time (Sedgwick, 2014a) and
therefore it was not possible to determine any causal inferences, nor explanatory
dimensions to observations. It also did not allow for sequencing of events between
independent and dependent variables nor any trend analysis on the study outcome
(Alexander, Lopes, Ricchetti-Masterson, & Yeatts, 2014; Van der Stede, 2014).
I did not collect information from the target population directly, and therefore
could not assess the demand side factors of a health system that potentially could affect
the uptake of cervical cancer screening. Factors like facility waiting times, distance to the
health facility, education level and other socioeconomic characteristics are important
factors that would have provided greater insights into the relationship between demand
for cervical cancer screening and the uptake of cervical cancer screening. In Nigeria and
in the United States, a low uptake of cervical cancer screening exists despite having all
the service delivery components. The low uptake is attributed to women’s perceptions of
risk and stigma that prevent them from using the services regardless of the availability of
services and trained staff. In Nigeria, a low level of knowledge about cervical cancer and
its prevention were identified as the major determinants of low cervical cancer screening
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uptake (Nwobodo & Ba-Break, 2016) whereas in the United States, health care system
distrust was a barrier to cervical cancer screening even after controlling for demographic,
socioeconomic and service delivery determinants (Yang, Matthews, & Hillemeier, 2011).
Other essential dimensions of health system determinants not covered in this study
include leadership, political will as well as financing for cervical cancer screening in the
country. The non-interventional nature of the study did not allow any cause- and-effect
analysis in the absence of variable manipulation.
Recommendations for Further Research
I have highlighted the important role of the availability of adequate numbers of
trained staff and the availability of all service delivery components in influencing the
uptake of cervical cancer screening in Swaziland. I found some data gaps in the health
information system relating to the referral of patients for services that were not available
within the facility that would need to be addressed to strengthen the health sector referral
and linkages systems as part of the Universal Health Coverage goals (Wong, 2015).
I recommend that researchers conducting studies on the determinants of cervical
cancer screening uptake and coverage should consider the inclusion of other health
system characteristics mentioned above that were not measured in this study to foster a
much better understanding of health facility related dynamics on the uptake of cervical
cancer screening among HIV positive AGYW. Additionally, the cross-sectional
quantitative nature of this study did not allow any causal inferences, nor explanatory
dimensions to the findings and therefore a mixed-methods or a prospective study of
uptake of cervical cancer screening could help provide an in-depth understanding of the
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demand and supply dynamics for the uptake of cervical cancer screening as well as
establish cause-and-effect relationships or associations among the independent variables.
Implications
Implications for Practice
While it is ideal to take a holistic approach in addressing the health system
barriers to uptake of cervical cancer screening in HIV positive AGYW, the current
financial climate in Swaziland precludes the Ministry of Health from doing so and
therefore prioritization of interventions based on their potential to maximize impact will
be necessary (Swaziland Ministry of Health, 2015a). The information generated from this
study may play a significant role in providing the evidence to design the cervical cancer
service delivery interventions to improve the uptake of screening services. The findings
point to three intervention areas: adequacy of numbers of trained health providers,
availability of all components for screening service delivery at the facility level, and
referrals of HIV positive adolescent girls for further management once they have a
positive screening test.
Like many lower- and middle-income countries, Swaziland experiences a human
resource for health shortage compounded with a maldistribution of existing human
resource between rural and urban areas (Campbell et al., 2013; Fulton et al., 2011; Spero,
McQuide, & Matte, 2011). Although the Ministry of Health drafted a task shifting brief
in 2010, no further progress has been made to finalize and implement this policy that
would encourage cross-training and redistribution of roles and scope of practice for
doctors, nurses and other lay health providers (Fulton et al., 2011). Information generated
by this study could be used to provide a rationale to finalize and pilot the policy.
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Secondly, procurement and supply chain management systems both at national
and facility levels should be strengthened to ensure that the diagnostics (acetic acid) and
equipment (speculum) to conduct the screening are continuously in stock and minimize
missed opportunities to screen HIV positive AGYW who are accessing HIV care and
treatment in the same clinics.
Robust referral and linkage mechanisms within a health system ensure that clients
are retained in care and receive appropriate follow up for their disease condition (Belhadj,
Rasanathan, Denny, & Broutet, 2013; Mwaka, Wabinga, & Mayanja-Kizza, 2013;
Nakisige, Schwartz, & Ndira, 2017). Ensuring that there is a reflexive referral mechanism
for the most vulnerable or high-risk clients provides a return on investment in terms of
less morbidity (less disease complications) and less cost in treating them (Binagwaho et
al., 2013; Mwaka et al., 2013). The Ministry of Health could adopt best practices from
elsewhere to ensure that HIV positive adolescent girls receive the referrals they need and
are linked to care to ensure the best health outcomes for them.
Implications for Positive Social Change
I examined a crucial health issue affecting a vulnerable and priority population in
Swaziland. With a youth bulge in the population and 30% of new HIV infections
occurring in women aged 15 – 24 years (Ginindza et al., 2018), preventing additional
morbidity from cervical cancer in this population is not only necessary but mandatory.
The uptake of cervical cancer screening in women in Swaziland remains sub-optimal
even in facilities where the services are routinely available, and this is even more
pronounced in AGYW. A limited understanding of the drivers of uptake of cervical
cancer screening may have contributed to this situation.
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I hope to foster positive social change by generating knowledge on the
institutional level health system factors that contribute to the low uptake of cervical
cancer screening among HIV-positive AGYW in Swaziland. This knowledge may help
policy makers, health managers, and service providers understand how to strengthen the
health system to improve uptake and, in the longer-term, coverage of cervical cancer
screening services in Swaziland.
The findings, if used contextually, could inform any public health interventions
aimed at improving uptake to cervical cancer screening in HIV positive AGYW in
similar settings, and ultimately reduce the high costs, morbidity and mortality related to
cervical cancer in this population.
For these reasons, the dissemination of the study findings will target the
Swaziland Ministry of Health and health facilities, the Ministry of Education, the Private
health sector and Community Based Organizations that work with adolescent girls and
young women. Local civil society organizations will also be targeted through policy, and
program strategic and implementation meetings, workshops and conferences. I will
publish the study findings in at least one peer-reviewed journal to further share its
findings with the international community.
Conclusion
The low uptake of cervical cancer screening in the absence of widespread HPV
vaccination in low- and middle-income countries like Swaziland that have high incident
rates of Cervical cancer, demonstrates the urgent need for innovative interventions to
provide screening for this preventable and curable cancer (Coleman et al., 2016; Ghebre
et al., 2017).
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This information produced by my research may be useful to guide the Swaziland
Ministry of Health in the allocation of resources for cervical cancer screening within
health facilities as well as inform country guidance and implementation plans. Further
research is needed to understand the demand side drivers that influence the uptake of
cervical cancer screening by HIV positive AGYW in Swaziland at both individual and
institutional levels. However, the findings from this study support the hypotheses that
adequate numbers of trained providers and the availability of all components of cervical
cancer screening services influence the uptake of cervical cancer screening among HIV
positive AGYW and I suggest that more emphasis needs to be placed on referring the
most vulnerable or highest risk group who have a positive screening result.
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